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“I am ignorant of absolute truth.  
But I am humble before my ignorance 
 and therein lies my honor and my reward.” 
 
Khalil Gibran 
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1. Abstract 
 
Mycotoxins, secondary metabolites produced by moulds, mainly Aspergillus spp., 
Fusarium spp. and Penicillium spp., are common contaminants of food and feed. The aim 
of this project was to evaluate: (i) the potential endocrine disruptor effects of fumonisin 
B1 (FB1), beauvericin (BEA), deoxynivalenol (DON) and zearalenone (ZEA) metabolites 
α-zearalenol (α-ZEA) and β-zearalenol (β-ZEA), alone and combined, using a bovine 
granulosa cell (GC) in vitro model and (ii) the individual and combined effects of FB1 and 
BEA on the intestinal barrier using Caco-2 cells cultured in vitro on semipermeable 
inserts.  
The results obtained indicated that FB1 alone at all tested doses (0; 0.5; 1; 1.5; 3; 6 µM) 
had no effects on GC proliferation and progesterone (P4) production. In the presence of 
β-ZEA at30 ng/mL (0.094 µM), FB1 at 30 ng/mL (0.042 µM) showed a stimulatory 
effect on GC numbers. Cell proliferation decreased after exposure to β-ZEA alone at 5.0 
mg/mL (15.6 µM) and FB1 with α-ZEA and β-ZEA at the same concentration. 
Regarding steroid production, FB1 at 30 ng/mL (0.042 µM ) and 100 ng/mL (0.13 µM 
amplified the inhibitory effect of β-ZEA at 30 ng/mL (0.094 µM) on estradiol (E2) 
production, while FB1 alone increased (P<0.05) IGF1-induced E2 production. FB1 in 
combination with β-ZEA decreased (P < 0.05) E2 production. FB1 at 1, 1.5 and 3 µM 
slightly inhibited (P < 0.05) E2 production. BEA at concentrations ≥ 3 µM was found to 
strongly decrease (P < 0.05) both steroid production and FB1 did not influence the 
effects of BEA. At 10 μM both mycotoxins decreased (P < 0.001) serum-induced GC 
proliferation. At 30 µM, BEA showed inhibitory effects on FSH plus IGF-1-induced 
CYP11A1 and CYP19A1 mRNA abundance (P < 0.05), whereas FB1 at 30 µM had no 
effect on CYP11A1 and CYP19A1 gene expression. 
As regards the effects of FB1 and BEA, alone and combined, on the Caco-2 intestinal 
barrier model data showed a TEER decrease after 1 h and 2 h of Bl exposure to BEA at 
0.5 and 1.5 µM and after 24 h of Bl exposure to BEA at 0.5 µM,  whereas after 24 h of 
Bl exposure, BEA at 3 and 6 µM was found to significantly (P < 0.05) increase TEER. 
FB1 had no effect on the intestinal barrier integrity and when combined with BEA the 
TEER increase induced by BEA was no longer observed. 
Cytokine release was observed only after exposure to BEA alone, and not in 
combination with FB1,  with an increase of IL-6 and IL8 release after apical exposure to 
3 and 6 µM and after basolateral exposure to 1.5, 3, 6 µM for IL-6 and only to 6 µM for 
IL-8. TNF- α  release was induced by Ap (0.5 -1.5 µM) and Bl (1.5 µM) exposure to 
BEA.   
Overall, these results provide information on in vitro toxicological effects of Fusarium 
mycotoxins. 
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2. General introduction 
 
2.1 Mycotoxins 
 
 Mycotoxins are secondary metabolites produced by molds that contaminate food 
and feed worldwide (Schollenberger et al., 2007). 25% of the world’s crop production is 
contaminated by mycotoxins and their global occurrence pose a serious risk to human 
and animal health (Pinton and Oswald, 2014). Mycotoxins produced by Aspergillus, 
Fusarium, and Penicillium genera are particularly significant for their ubiquity and toxicity 
(Osweiler, 2000).  
There are several factors that influence the presence of mycotoxins in foods or feeds: 
extrinsic and intrinsic factors (Hussein and Brasel,  2001). Extrinsic factors include 
environmental conditions such as storage, temperature and humidity (Hussein and 
Brasel,  2001) while intrinsic ones include the strain specificity and the strain variation 
(Hussein and Brasel,  2001). Mycotoxins have a wide spectrum of toxic effects and the 
nature and the intensity of these effects are not only related to the time and dose of 
exposure, but also to the possible co-occurrence of mycotoxins that can result in 
additive, synergic or antagonistic toxicological effects (Fink-Gremmels, 1999). Chronic 
exposure to mycotoxins (Hussein and Brasel, 2001; Fink-Gremmels and Malekinejad,  
2007) results in reduced feed intake, loss of body weight, immune-suppression with a 
subsequent increased susceptibility to infections, and possible effects on reproductive 
function (Fink-Gremmels and Malekinejad, 2007; Pestka, 2007; Voss et al., 2007).   
 
 
2.2 Fusarium mycotoxins 
 
 Fusarium molds are commonly found on commodities in Europe, America and 
Asia and are considered the most prevalent species in the northern hemisphere (Creppy, 
2002). Fusarium spp. synthesize a wide range of mycotoxins (Flannigan, 1991; Glenn, 
2007) and the most important in terms of impact to animal health and production are 
fumonisins, trichothecenes and zearalenone (D'Mello et al., 1999; Uhlig et al., 2007; 
Jestoi, 2008).  
Fusarium species require a moisture content of 25% (Newman and Raymond, 2005) and 
toxinogenesis is strongly influenced by this factor (Sweeney and Dobson, 1998). 
Consumption of a mycotoxin-contaminated diet may induce acute and chronic effects 
resulting in a broad variety of toxicological effects in animals (D'Mello et al., 1999; 
Binder et al., 2007; Smith, 2012; Cortinovis et al., 2014) 
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2.2.1 Worldwide contamination of Fusarium mycotoxins 
 
 The presence of mycotoxins depends on several factors such as their interactions 
with other organisms on the substrate where they coexist, the production site, humidity, 
temperature and the agricultural and post-harvest practices (Hussein and Brasel,  2001; 
Ferre, 2016). Several surveys reported the occurrence of mycotoxins relevant to the feed 
industry in different regions particularly with respect to fumonisins (Boutigny et al., 
2012; Garrido et al., 2012) and deoxynivalenol (DON) (Boutigny et al., 2012; Grajewski 
et al., 2012). Rodrigues and Naehrer (2012) reported that fumonisins, DON and 
zearalenone (ZEA) were present in 64%, 59% and 45% of analyzed samples, 
respectively while, in a study conducted by Yoshinari et al. (2016) beuvericin (BEA) was 
found in 34% of the samples. As reported by Binder et al. (2007), more than half of the 
samples collected in Europe were contaminated as well as one third of the Asian-Pacific 
ones. The European Commission (EC) has established guidance levels for the presence 
of some Fusarium mycotoxins in animal feed (EC,  2006). For fumonisins (fumonisin B1 
and B2) the guidance values are 60 mg/kg for maize and maize products, 5 mg/kg for 
complementary and complete feedingstuffs for pigs, horses, rabbits and pet animals, 10 
mg/kg for fish, 20 mg/kg for poultry, calves (<4 months), lambs and goat kids and 50 
mg/kg for adult ruminants (>4 months) and mink (EC, 2006). Regarding DON the EC 
guidance values are 8 mg/kg for cereals and cereal products with the exception of corn 
by-products (12 mg/kg) and 5 mg/kg for complementary and complete feedingstuffs 
with the exception of feedingstuffs for pigs (0.9 mg/kg) and for calves (<4 months), 
lambs and goat kids (2 mg/kg) (EC, 2006; Pinton and Oswald, 2014). The ZEA EC 
guidance values recommended for complementary and complete feedingstuffs for 
piglets/gilts, sows/fattening pigs, and calves/dairy cattle/sheep/goats are 0.1, 0.25 and 
0.5 mg/kg, respectively (EC, 2006; Streit et al., 2012). The ZEA EC guidance values for 
cereals/cereal products and corn by-products are 2 and 3 mg/kg, respectively (EC, 
2006). 
 
 
2.2.2 Fumonisins 
 
 Fumonisins are a family of mycotoxins mainly produced by Fusarium verticillioides, 
Fusarium proliferatum, Fusarium napiforme and Fusarium nygamai that have been shown to 
occur worldwide at significant levels in corn and corn by-products (Voss et al., 2007; 
Glenn, 2007). Fumonisins have been found to commonly occur in combination with 
deoxynivalenol (DON), zearalenone (ZEA) and beauvericin (BEA) in cereal grains and 
animal feed (Jestoi, 2008). Fumonisins are divided into four groups known as A, B, C 
and P (Marasas et al., 1984; Alberts et al., 1990; Yazar and Omurtag, 2008). The most 
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important is the B group that includes fumonisin B1 (FB1), B2 (FB2) and B3 (FB3) with 
FB1 (Fig. 2.1) being the most significant in terms of toxicity and occurrence (EFSA, 
2005). FB1 induces different species-specific effects in animals including 
leukoencephalomalacia in horses and pulmonary edema in pigs (Marasas et al., 1988; 
Ross et al., 1993; Voss et al., 2007). Cattle are considerably less sensitive to FB1 than 
horses and pigs (Fink-Gremmels, 2008) and signs of liver and kidney injury have been 
reported in cattle only after exposure to very high concentrations of FB1 (Osweiler et al., 
1993; Baker and Rottinghaus, 1999; Mathur et al., 2001). In ruminants FB1 has a very 
low bioavailability , is poorly degraded in the rumen (Caloni et al., 2000) and is found 
unmetabolized in feces (Cavret and Lacoeur, 2006). The mechanisms of toxicity for FB1 
are complex and may involve several molecular sites (Voss et al., 2007). FB1 bears a 
remarkable structural resemblance to the long-chain (sphingoid) base backbones of 
sphingolipids and thus impairs sphingolipid biosynthesis (Wang et al., 1991; Merrill et al., 
2001; Voss et al., 2002; Voss et al., 2007). The inhibition of ceramide synthase leads to 
the accumulation of sphingoid bases and to the depletion of complex sphingolipids, 
which interfere with the function of some membrane proteins (Wang et al., 1991; Merrill 
et al., 2001; Voss et al., 2002; Voss et al., 2007). Thus, the mechanism of toxicity of FB1 
is linked to its ability to disrupt the sphingolipid metabolism and the subsequent adverse 
effects on cell regulation (Wang et al., 1992; Marasas et al., 2004; Smith., 2012).  
The International Agency for Research on Cancer (IARC) classified FB1 as a possible 
carcinogen (class 2B) for humans (IARC, 2003).  
 
 
 
 
Figure 2.1: Chemical structure of fumonisin B1 (FB1). 
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2.2.3 Trichothecenes 
 
 Trichothecenes are a family of Fusarium mycotoxins commonly found in cereal 
grains such as corn, wheat, rye, barley and oats. The family is subdivided into four 
groups (A, B, C and D) according to their chemical structure. Type A trichothecenes 
including T-2, HT-2 toxin, neosolaniol and diacetoxyscirpetol and type B including 
DON and its 3- acetyl and 15-acetyl derivates, nivalenol and fusarenon X are the most 
important (Escriva et al., 2015).  
Trichothecenes inhibit the synthesis of RNA and DNA interfering with cellular 
metabolic activities and causing cell death (Thompson and Wannemacher, 1990) and are 
able to readily bind to eukaryotic ribosomes, in particular to the 60S ribosomal subunits, 
inhibiting protein synthesis (Pestka, 2010). 
The general clinical signs of trichothecene toxicosis commonly include loss of appetite, 
vomiting, diarrhea, leukocytosis and gastrointestinal hemorrhage (Pestka and Smolinski, 
2005; Maresca, 2013; Blajet-Kosicka et al., 2014; Pinton and Oswald, 2014). Ruminants 
are less sensitive to trichothecene toxicity whereas pigs and poultry are the most 
susceptible species to DON and T-2 toxin respectively (Pestka and Smolinski, 2005; 
Maresca, 2013; Pizzo et al., 2016). 
 
 
2.2.4 Deoxynivalenol 
 
 Deoxynivalenol (DON), also known as vomitoxin, belongs to the type B group of 
trichothecenes and occurs commonly in grains such as maize and wheat but also in rice, 
oats and sorghum (Pinton and Oswald, 2014). DON has been implicated in farm animal 
disease outbreaks in many areas of the world and is considered one of the most 
hazardous food-associated mycotoxin for human health (Maresca, 2013; Pinton and 
Oswald, 2014). 
Structurally, DON (Fig. 2.2) is a polar organic compound containing 3 free hydroxy 
groups (-OH), which are associated with its toxicity (Sobrova et al., 2010). The 
mechanism of action of DON is known to be related to its ability to bind eukaryotic 
ribosomes and inhibit protein synthesis by blocking translation and inhibiting the 
elongation of peptide chains (Larsen et al., 2004; Pestka, 2010). Moreover, DON can 
also induce cell apoptosis activating the mitogen-activated protein kinases (MAPKs) 
(Larsen et al., 2004; Pestka et al., 2010; Li et al., 2014). After ingestion of highly DON 
contaminated food common clinical signs include abdominal pain, vomit, diarrhea, 
leukocytosis and blood in stool. Loss of weight and altered immune function have been 
frequently  observed after chronic exposure (Pestka and Smolinski, 2005).  
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DON was found to be able to cross the intestinal barrier modifying cellular functions 
and causing cell death in pigs (Maresca et al., 2013). In vitro studies carried out with the 
cell lines Caco-2, IPEC-1 and IPEC-J2 demonstrated that DON is able to impair the 
intestinal barrier function and may have serious consequences for human and animal 
health (Van de Walle et al., 2010; Awad et al., 2011; Vandenbroucke et al., 2011).  
Ruminants are considered less susceptible to the adverse effects of DON because DON 
is rapidly converted in the rumen into de-epoxy DON (DOM1) that is less toxic 
compared to the parent compound (Cotè et al., 1986; Fink-Gremmels, 2008). 
 
 
 
Figure 2.2: Chemical structure of deoxynivalenol (DON). 
 
 
 
2.2.5 Zearalenone 
 
 Zearalenone (ZEA) (Fig. 2.3) is a widespread mycotoxin that is of great interest 
due to its toxic effects on animals (Fink-Gremmels, 1999; Fink-Gremmels and 
Malekinejad, 2007; Zinedine et al., 2007). ZEA is an estrogenic mycotoxin produced by 
several Fusarium species including F. culmorum, F. graminearum, F. equiseti and F. 
crookwellense. This mycotoxin commonly contaminates wheat, rice, maize, barley and 
other crops (Fink-Gremmels and Malekinejad, 2007). ZEA is a resorcyclic acid lactone, 
chemically described as 6-[10-hydroxy-6-oxo-trans-1-undecenyl]-B-resorcyclic acid 
lactone (Zinedine et al., 2007). This particular structure resembles several characteristics 
of steroid hormones and consents ZEA to bind estrogen receptor α (ESR1) and 
estrogen receptor β (ESR2) (Zinedine et al., 2007). In this way ZEA can act as an agonist 
and partial antagonist of estradiol (Malekinejad et al., 2007), thus inducing estrogenic 
effects such as hyperestrogenism in all animal species (Böhm and Razzai-Fazeli, 2005).  
In pigs, which are more sensitive than other species,  ZEA is mainly biotransformed in 
the liver in α-Zearalenol (α-ZEA), which showed higher affinity to bind to estrogen 
receptors than ZEA and β-Zearalenol (β-ZEA) (Malekinejad et al., 2007). Common 
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clinical signs of ZEA intoxication are related to the hyperstimulation of estrogen-
dependent tissues (Malekinejad et al., 2007). In gilts clinical signs include reddening and 
swelling of the vulva and an enlarged uterus, whereas in cycling sows fertility is impaired 
(Malekinejad et al., 2007; Minervini and Dell’Aquila, 2008). 
In ruminants, ZEA is converted in the rumen mainly into α-ZEA (Fig. 2.4) and, to a less 
extent, in β-ZEA (Fig. 2.5) (Abidin and Khatoon, 2012; Winkler et al., 2014) but the rate 
of absorption of the more polar α-ZEA is poor.  
In cow, infertility, reduced milk production and hyperestrogenism have been reported 
(Minervini and Dell’Aquila, 2008). 
 
 
 
Figure 2.3: Chemical structure of zearalenone (ZEA). 
 
 
 
 
Figure 2.4: Chemical structure of α-zearalenol (α-ZEA). 
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Figure 2.5: Chemical structure of β-zearalenol (β-ZEA). 
 
 
 
2.2.6 Beauvericin 
 
 Beauvericin (BEA) (Fig. 2.6) is a mycotoxin firstly identified in the culture of the 
soil-borne entomopathogenic fungus Beauveria bassiana but also synthesized by several 
Fusarium spp. parasitic to important cereal grains such as corn, wheat, rice and barley 
(Leslie and Summerell, 2006). High contamination levels, up to 500 mg/kg of BEA, 
have been reported in commodities raising serious concerns about the potential impact 
of this fusariotoxin on human and animal health (Uhlig et al., 2007; Jestoi, 2008). BEA is 
a ionophoric molecule that can form stable and lipophilic complexes with cations and 
transport them into the lipophilic phase (Hilgenfeld and Saenger, 1982; Jestoi, 2008; 
Schoevers et al., 2016). According to this, the primary toxic action of BEA is considered 
to be related to its ionophoric properties. BEA is thus able to promote the transport of 
several cations through membranes disturbing the cell homeostasis (Hilgenfeld and 
Saenger, 1982; Jestoi, 2008; EFSA, 2014; Schoevers et al., 2016). It is well-established 
that an increase in the intracellular concentration of cations such as calcium and the 
subsequent activation of calcium-dependent endonucleases lead to DNA fragmentation 
which is related to several chronic diseases in humans and in animals with many 
different adverse health effects (Speijers and Speijers, 2004; Kouadio et al., 2007). In 
recent studies BEA was found to exert potent cytotoxicity against different cell lines 
(Jestoi, 2008; Ruiz et al., 2011; Prosperini et al., 2012; Mallebrera et al., 2016). 
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Figure 2.6: Chemical structure of beauvericin (BEA). 
 
 
 
2.3 Fusarium mycotoxins and effects on reproductive function 
 
2.3.1 Fumonisins 
 
 The potential reproductive toxicity of fumonisins has been only recently 
investigated. Studies demonstrated that fumonisin B1 (FB1) has the potential to impair 
fertility in pigs and rabbits delaying puberty and impairing semen quality and 
spermatogenesis (Ogunlade et al., 2006; Gbore and Egbunike, 2008; Ewuola and 
Egbunike, 2010). Moreover, in vitro studies showed that FB1 affects some functional 
parameters of equine spermatozoa, such as sperm chromatin stability and motility 
(Minervini et al., 2010). Recently, FB1 was found to directly affect in vitro porcine 
granulosa cell (GC) proliferation, steroid production and gene expression (Cortinovis et 
al., 2014). FB1 at 10 µM decreased cell proliferation and strongly increased progesterone 
(P4) production thereby suggesting that this Fusarium mycotoxin may affect the normal 
follicle growth and oocyte survival and interfere with the endocrine regulation of the 
developing follicle in swine (Cortinovis et al., 2014). 
Regarding a possible interaction between FB1 and other Fusarium mycotoxins, a 
significant interaction between FB1 at 10 µM and α-ZEA at 9.4 µM was found on P4 
production (Cortinovis et al. 2014). On the contrary, no significant interaction was 
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observed when GC were treated with FB1 at 10 µM combined with DON at 3.4 µM 
(Cortinovis et al. 2014). 
 
 
2.3.2 Deoxynivalenol 
 
 The potential of deoxynivalenol (DON) to act as endocrine disruptor has been 
investigated in previous studied and is the object of increasing interest (Medvedova et al., 
2011; Han et al., 2016).  
In previous studies, DON at 10 µM was found to affect the process of follicular 
maturation with a decrease of the reserve pool of follicles resulting in a significant 
decrease in the number of normal follicles (Gerez et al., 2016). These results are in 
agreement with previous studies, where porcine cumulus-oocyte complexes exposed to 
DON at 0.02, 0.2, or 2 μM showed an increase in cumulus cell death and degeneration, 
with a consequent significant reduction in the proportion of oocytes that reached 
metaphase II (Schoevers et al., 2010). Concerning the effect of DON on GC 
proliferation and steroidogenesis in pigs, Ranzenigo et al. (2008) reported DON 
increasing GC number at 0.034 μM and 0.34 μM and drastically reducing it at 3.4 μM. 
Differently, Pizzo et al. (2016) found that DON did not alter cell proliferation of bovine 
GC at concentrations ranging from 0.1 to 3.3 µM.  
The effects of DON on steroidogenesis have been also investigated with the bovine GC 
model (Pizzo et al., 2015, 2016). DON, in presence of FSH and IGF1, was found to 
inhibit E2 release at concentrations ranging from 0.1 to 3.3 µM and P4 production at 
0.33 and 3.3 µM (Pizzo et al., 2015). In absence of IGF1, DON at 3.3 µM significantly 
up-regulated CYP19A1 mRNA abundance, but had no effect on CYP11A1 mRNA 
abundance in bovine GC (Pizzo et al., 2016). These results seem to support the theory 
that DON promotes stability of several mRNAs interfering with post-transcriptional 
processes and avoiding their rapid degradation with several adverse effects on 
steroidogenesis in cattle (Pizzo et al., 2015; Pizzo et al., 2016). 
 
 
2.3.3 Zearalenone 
 
 It is already well established that zearalenone (ZEA) and its metabolites have 
strong estrogenic activities, being able to cause alteration in the reproductive tract (Fink-
Gremmels, 1999; Malekinejad et al., 2007; Denli et al., 2017). Particularly, ZEA can 
induce estrogenic effects such as hyperestrogenism, anoestrus, ovarian atrophy and 
changes in the endometrium (Böhm and Razzai-Fazeli, 2005; Malekinejad et al., 2007; 
Minervini and Dell’Aquila, 2008). The effect of ZEA depends on several factors 
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including the reproductive status (prepuberal, cycling or pregnant) of the affected animal 
and the administration time and dose (Price et al., 1993; Tiemann and Dänicke, 2007; 
Döll and Dänicke, 2011; Holda and Glogowski, 2014). A correlation between the level 
of ZEA in mg/kg and the length of anestrus in days was found by Young and King 
(1986) who observed an increase of the weaning-to-estrus interval when increased ZEA 
was fed. 
Döll et al. (2004) reported that after 5 weeks of feeding piglets in prepuberal stuatus with 
feed contaminated by ZEA up to 0.42 mg/kg, the mean weight of the uteri was 
significantly increased. ZEA and its metabolite adverse effects on estrus were also 
reported in a recent study (Daia et al., 2016). This in vivo study provided evidence that 
ZEA at 1.04 mg/kg accelerated the development of the ovaries in post-weaning piglets 
confirming that a diet contaminated by ZEA can accelerate the development of ovarian 
follicles in post-weaning piglets possibly leading to subsequent reproductive disorders 
(Daia et al., 2016). In another study, Minervini et al. (2006) studied the effects of ZEA 
and its metabolites with an in vitro culture system of equine GC. The results of this study 
showed GC apoptosis after exposure to ZEA at 0.1 μM. A recent study confirmed that 
ZEA induces necrosis and GC death in a dose-dependent manner via a caspase-3- and 
caspase-9-dependent mitochondrial pathway (Zhu et al. 2012). 
The effects of α-ZEA and β-ZEA, ZEA metabolites, on pig oocytes have been 
investigated (Alm et al., 2002). Oocyte maturation rate resulted in a significant decrease 
when oocytes were exposed for 48 h to α-ZEA at concentrations up to 7.5 µM (Alm et 
al., 2002). Differently, β-ZEA showed a significant effect only at 30 µM (Alm et al., 
2002). In a subsequent study, Tiemann et al. (2003) found α-ZEA and β-ZEA at 
concentrations of 15 and 30 µM to inhibit in vitro the FSH stimulated P4 synthesis in 
porcine GC (Tiemann et al., 2003). The ability of ZEA metabolites to affect steroid 
production in pig GC has also been reported by  Ranzenigo et al. (2008) and Cortinovis 
et al. (2014). In both studies α-ZEA primarily increased progesterone (P4) production 
induced by FSH and IGF1, whereas estradiol (E2) production exhibited a biphasic 
dose–response to α-ZEA in the study conducted by Ranzenigo et al. (2008) and was not 
affected in the study of Cortinovis et al. (2014). Specifically, α-ZEA at 0.094 µM and 9.4 
µM increased and decreased E2 production, respectively (Ranzenigo et al., 2008), 
whereas no effects on E2 production was reported after exposure to α-ZEA at 9.4 µM  
(Cortinovis et al., 2014). In comparison to monogastric, ruminants seem less susceptible 
to ZEA toxicity (Upadhaya et al., 2010; Pizzo et al., 2016). In rumen ZEA is converted 
into α-ZEA and β-ZEA, even if ZEA also undergoes hepatic biotransformation (Seeling 
et al., 2006). In cows the poor rate of absorption of the ZEA metabolites explains why 
clinical signs of hyperestrogenism are observed scarcely (Fink Gremmels, 2008). 
Estrogenic effects of ZEA in cows were found only after the ingestion of highly 
contaminated feed or after long-term exposure to contaminated feed materials (Fink 
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Gremmels, 2008). In a recent study Pizzo et al. (2016) determined the impact of α-ZEA 
and β-ZEA on GC function evaluating cell proliferation, steroid production and gene 
expression using a bovine GC model. Based on the results reported, in absence of IGF1, 
α-ZEA at 3.1 µM had inhibitory effects on cell proliferation, whereas it was found to 
inhibit both E2 and P4 production in GC at concentration ranging from 0.09 to 3.1 µM 
in presence of IGF1 (Pizzo et al., 2016). Regarding β-ZEA, an inhibitory effect on cell 
numbers was found at 31 µM both in presence and absence of IGF1, while E2 and P4 
production was increased in the absence IGF1. The results obtained by Pizzo et al. 
(2016) on cell proliferation are in agreement with previous studies on pig GC conducted 
by Tiemann et al. (2003) and Ranzenigo et al. (2008) which demonstrated the adverse 
effects of β-ZEA. Regarding steroidogenesis previous studies on pigs (Ranzenigo et al., 
2008) showed an increase in E2 production at 0.09 µM whereas in cattle no results were 
obtained at the same concentration (Pizzo et al., 2016), suggesting a species-specific 
effect. 
In relation to the possible interaction between ZEA metabolites and gene expression 
Pizzo et al. (2016) demonstrated that α-ZEA in the presence of IGF1 did not affect 
CYP11A1 and CYP19A1 mRNA abundance. However, in previous studies on pigs 
Tienmann et al. (2003) showed that α-ZEA at 5 µM was able to increase CYP11A1 
protein expression, whereas Ranzenigo et al. (2008) showed that α-ZEA at 9.4 µM 
decreased CYP11A1 mRNA abundance in porcine GC. 
 
 
2.3.4 Beauvericin 
 
 Beauvericin (BEA) is considered an emerging  mycotoxin (Uhlig et al., 2007; 
Jestoi, 2008; EFSA, 2014). The ability of BEA to increase the cytoplasmic cation 
concentration may play an important role in the induction of cell apoptosis (Jow et al., 
2004). Contaminations, up to 500 mg/kg of BEA, have been reported in commodities 
raising serious concerns about the potential impact of this mycotoxin (Jestoi, 2008). In 
previous studies BEA was found to exert potent cytotoxicity on pig, rodent and human 
cell lines (Klaric et al., 2006; Ruiz et al., 2011; Prosperini, et al., 2012). Recent studies, 
with estrogen, androgen, progestagen and glucocorticoid reporter gene assays (RGAs), 
demonstrated that BEA has the potential to modulate the endocrine system by 
antagonism of nuclear receptor transcriptional activity (Fernández-Blanco et al., 2016).   
Information on possible reproductive effects of  BEA in domestic animals is lacking. 
In a recent study Schoevers et al. (2016) showed that BEA reduced the developmental 
competence of both the maturing oocyte and the two-four cell stage embryo in pigs, and 
that BEA only affected the rate of developing embryos. The authors exposed the 
cumulus-oocyte-complexes and developing embryos to BEA at concentrations ranging 
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from 0.31 to 10 μM and they studied the effects of this mycotoxins on viability, 
progesterone synthesis and apoptosis (Schoevers et al., 2016). As reported in this study 
BEA was toxic to embryos, oocytes and cumulus cells at concentrations exceeding 0.5 
μM. 
 
 
2.3.4.1 Granulosa cells in vitro model  
 
The function of granulosa cells (GC) is essential in the process of folliculogenesis and 
oocyte growth and development (Petro et al., 2012). In fact GC are crucial in the 
delivery of nutrients to the oocyte and they play an important role in the ovarian 
steroidogenesis (Scaramuzzi et al., 2011). The use of the GC model to investigate the 
molecular mechanisms of several compounds, their adverse effects and the mechanisms 
underlying the process of ovarian follicular atresia has been already reported (Jolly et al., 
1994; Kwintkiewicz et al., 2010). For its characteristics the GC model provides the 
opportunity to examine the factors that influence oocyte competence in a way not 
previously accessible (Dias et al., 2014). As reported by several authors the bovine GC  
model is not only able to reproduce the in vivo situation, but also allows comparable 
studies with humans (Anderiesz et al., 2000). Anderiesz et al. (2000) reported the 
response of bovine and human oocytes to pure recombinant preparations of human 
follicle stimulating hormone (FSH) and luteinizing hormone (LH) for meiotic 
maturation and subsequent developmental competence in vitro. Specifically, no 
significant difference was observed in terms of maturation of oocyte to metaphase II 
and embryonic development between bovines and humans (Anderiesz et al., 2000). 
These results are in agreement with subsequent studies where similarities in terms of 
embryonal genome activation and duration of preimplantation development were found, 
confirming that the bovine GC model represents a good in vitro model to evaluate the 
effects of contaminants in both bovines and humans (Petro et al., 2012).  
 
 
 
2.4 Fusarium mycotoxins and in vitro intestinal models 
  
2.4.1 In vitro intestinal models 
 
 The intestinal tract represents the first interface between food and the internal 
body and is the primary target of dietary compounds, thus in vitro intestinal models are of 
great interest for several toxicological studies (Meca et al., 2011). The intestinal epithelial 
monolayer consists of several subsets of epithelial cells that constitute a physical and 
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biochemical network for the maintenance of the homeostasis in the gastrointestinal tract 
(Goto and Kiyono, 2012). The main functions of the intestinal epithelium include the 
protection of the body against potentially toxic compounds or microorganisms, and  the 
prevention of the loss of important compounds such as water and solutes (Gordon et 
al., 2015). There are several in vitro intestinal models that can mimic oral toxicity with 
different advantages, limitations, issues and needs (Table 1).  
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Tabel 1: Models for intestinal absorption  (Gordon et al., 2015) 
 
 
Models for intestinal absorption 
 
 Examples   Advantages   Limitations Issues and 
 needs 
    Memo 
 
Cell-based  
systems 
 
 
 
 
 
 
 
Caco-2 monolayer 
(e.g. CacoReady, 
Advancell) 
 
 
 
 
 
 
 
- easily 
accessible 
- regulatory 
 acceptance for 
 BCS 
classification       
- reproducible 
- metabolically 
competent 
- information on 
active transport 
- Papp useful  
PBPK or 
bioavailability 
screening (e.g.  
BCS class) 
- poor 
correlation 
to in vivo rat  
absorption data 
(since, e.g. no 
available human 
absorption data 
for pesticides) 
 
- technical 
limitations 
(sufficient water 
solubility needed, 
dependence on 
shipment)  
- definition of 
acceptance criteria 
(e.g. applicability 
domains, reference 
datasets, integrity 
tests,..?) 
 
- higher  
standardization of 
the method 
including  
standardized 
integrity tests 
(SOP?) 
 
- think about new 
approaches (new 
in vitro models? 
in silico models? 
combination of 
both?) that cover 
all pathways 
 
- simple system,  
applicable for 
screening purposes 
 
- applicable for 
mixtures    
- no routine 
in the 
regulatory 
context of 
chemicals and 
food, 
data 
from 
intestinal             
in vitro 
 models can 
be treated as 
mechanistic 
add-on 
information 
 
 
 
- clarify 
transporter 
activity and  
extent of  
activity in 
Caco-2 model 
 
 
 
 
 
 
 
T84 polarized cells 
 
 
 
 
 
 
- depicts apical 
and basal surface 
- reflects villi 
like 
structures 
- well defined 
cellular junctions 
- easy to assess 
TEER for 
permeability 
measurements 
 
 
 
- 7-10 days for 
polarization  
 
- technical 
limitations 
 
Artificial 
surrogates 
 
 
 
GiT-PAMPA (Pion) 
 
 
 
- easily 
accessible 
- standardized 
- reproducible 
- Papp useful for 
PBPK 
 
- only passive 
diffusion 
- no metabolism 
- poor 
correlation  
to in vivo rat  
absorption data 
- technical 
limitations 
(sufficient water- 
solubility, UV- 
activity needed) 
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Among the intestinal models the most common are represented by immortalized human 
adenocarcinoma cell lines such as Caco-2 or T84 (Raffatellu et al., 2005; Khare et al., 
2009; Tran et al., 2010). Caco-2 and T84 models are common to many studies, however 
each epithelial barrier model has specific characteristics for application (Ward and Tse, 
1999). For example, it is well known that there are some significant differences between 
polarized Caco-2 and T84 cells. Caco-2 cell monolayers exhibit lower Trans-Epithelial 
Electrical Resistance (TEER) values on confluence than T84 cells (Gordon et al., 2015). 
An increase in the permeability of intestinal epithelial cells is correlate to a decrease in 
TEER values and this parameter has been used as an indicator of early sub-lethal 
epithelial toxicity (McCall et al., 2009; Gordon et al., 2015). Moreover, T84 cells differ 
from Caco-2 cells in Na+-dependent nucleoside transport systems (Ward and Tse, 1999). 
Other differences between these cell lines have been described before by several authors 
(McCool et al., 1990; Ward and Tse, 1999; Gordon et al., 2015). For example, compared 
to Caco-2 cells, T84 cells produce mucin in culture and are able to respond to external 
stimuli to exert innate immune responses thus mimicking more closely the intestinal 
surface conditions (McCool et al., 1990; Ward and Tse, 1999; Ou et al., 2009; Gordon et 
al., 2015). Culture-related conditions were shown to influence the expression of Caco-2 
cell activity (Delie and Rubas, 1997; Sambuy et al., 2005; Turco et al., 2011). In order to 
reduce the variability, the TC7 clone was obtained from a late passage of the parental 
Caco-2 line (Turco et al., 2011). TC7 cells have demonstrated to consist of a more 
homogeneous population with more developed intercellular junctions, however Turco et 
al. (2011) reported the non-suitability of TC7 cells to predict intestinal absorption of 
highly lipophilic or poorly absorbed compounds (Turco et al., 2011).  
Previous studies reported that IPEC-1 and IPEC-J2 cell lines are considered for their 
suitability good in vitro intestinal models (Lu et al., 2002; Schierack et al., 2006). Both cell 
lines are undifferentiated and derived from small intestine of piglets, however, while 
IPEC-1 derived from the small intestine, IPEC-J2 derived from mid-jejunum 
(Berschneider, 1989). IPEC-J2 cells grown in monolayers were first employed in 
transepithelial ion transport and cellular proliferation studies (Kandil et al., 1995; Rhoads 
et al., 1997). Neither of these cell lines is immortalized and therefore they are considered 
better models of normal porcine intestinal epithelium than transformed cell lines (Koh et 
al., 2007). 
 
 
2.4.2 Caco-2 in vitro intestinal model  
 
 Caco-2 cells, originally isolated from a human colorectal adenocarcinoma, 
represent a very well characterized in vitro model of epithelial barrier for intestinal 
absorption and metabolism studies (Fogh et al., 1977; Gilman and Cashman, 2006; Meca 
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et al., 2011; Prosperini et al., 2012). This cell line represents a good cell culture model for 
the study of absorption and metabolism in the small intestine, as well as the most used 
model for pharmacological and toxicological studies (Delie and Rubas, 1997; Le Ferrec 
et al., 2001; Sambuy et al., 2005). To better mimic the in vivo conditions of the intestine, 
Caco-2 cells are cultured on permeable filter supports which allow access of ions and 
nutrients to both sides of the cell monolayer (Turco et al., 2011). Caco-2 cells 
demonstrated to be highly dependent on culture conditions including medium 
composition and pH, seeding density and substrate nature (Ranaldi et al., 2003). 
However, this cell line is considered a suitable physiological model for studies of toxicity 
and transport of nutrients, cations and contaminants (Hidalgo et al., 1989; Artursson et 
al., 2001; Martel et al., 2001; Caloni et al., 2006; Caloni et al., 2012) (Fig. 2.7). When 
grown on a permeable filter support for 21 days Caco-2 cells are able to polarize and 
differentiate according to some typical enterocytic pathway, with apical microvilli and a 
basolateral surface, similar to the cellular surface in contact with intestinal vascular and 
lymphatic circulation (Pinto et al., 1983; Artursson et al., 2001; Caloni et al., 2012; 
Ferruzza et al., 2012). The Caco-2 cell full differentiation and polarization process has 
been associated with Trans-Epithelial Electrical Resistance (TEER) values exceeding 300 
Ω cm2 (Van Breemen and Li, 2005). In fact after confluence, TEER and permeability of 
marker molecules are usually used to investigate the integrity of the epithelial barrier 
tight junctions (Pinton et al., 2009). Specifically, TEER quantifies ion movement across 
cellular barriers and is considered a good indicator of the integrity of the epithelial 
barrier (De Angelis and Turco, 2011).   
 
 
 
Figure 2.7: Transwell insert which separate the Apical (Ap) compartment from the basolateral (Bl) 
compartment. 
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Caco-2 cells also express some transporters and efflux proteins as well as metabolic 
enzymes that are normally expressed in the gut (Sun et al., 2002; Sambuy et al., 2005). In 
vitro methods based on chemical transport across Caco-2 monolayers are at present the 
most frequently and successfully exploited procedures to investigate intestinal 
permeability in humans (Yee, 1997; Yamascita et al., 2000; Van Breemen and Li., 2005; 
Nigsch et al., 2007), giving good correlation with the fraction absorbed in humans (Van 
Breemen and Li., 2005; Nigsch et al., 2007).  
Passive diffusion is not the only absorption mechanism of xenobiotics, the active 
transport and efflux systems play also an important role (Yang, 2013). There are many 
intestinal transporters expressed on the small intestine and among these there are two 
main groups: the efflux (ABC family) and uptake (SLC family) transporters (Liu et al., 
2013). Specifically, ABC transporters are composed by P-glycoprotein (P-gp), multidrug 
resistance 1 (MDR1), multidrug resistance-associated protein 2 (MRP2) and breast 
cancer resistance protein (BCRP) (Liu et al., 2013), whereas among SLC transporters we 
can found the organic cation transporters (OCTs), novel organic cation transporters 
(OCTNs) organic anion-transporting polypeptides (OATPs) and H+/peptide 
cotransporter (PEPT1) (Liu et al., 2013). 
 
 
2.4.3 Fusarium mycotoxins and in vitro studies with intestinal barrier 
 
 Different in vitro models have been used to evaluate the effects of Fusarium 
mycotoxins on the intestinal barrier (Table 2). Table 2 summarizes the cell models used 
to assess the impact of the principal Fusariotoxins on the intestinal epithelium. 
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Tabel 2: Fusarium mycotoxins and in vitro studies with intestinal models 
 
 
Mycotoxin Model References 
FB1 
Caco-2 cells 
Stevens et al., 1997; Caloni et al., 
2002; De Angelis et al., 2005; 
Kouadio et al., 2005; Kouadio et 
al., 2007; Fernández-Blanco et al., 
2016; Romero et al., 2016. 
 
Ipec-1 
Bouhet et al., 2004; Bouhet and 
Oswald, 2007; Loiseau et al., 2007 
 
Ipec-J2 
Goossens et al., 2012; Wang et al., 
2013 
HT-29 Minervini et al., 2014 
SW742 Mahamoodi et al., 2012 
BEA 
Caco-2 cells Fernández-Blanco et al., 2016 
Ipec-1 Springler et al., 2016 
DON 
Caco-2 cells 
Kasuga et al., 1998; Kouadio et al., 
2005; Sergent et al., 2005; Manda 
et al., 2015; Vejdovszkya et al., 
2016;  
Ipec-1 
Pinton et al., 2009; Pinton et al., 
2010; Diesing et al., 2011; 
Alassane-Kpembi et al., 2015 
Ipec-J2 
Gu et al 2014; Broekaert et al, 
2016; Gu et al 2016 
ZEA 
Caco-2 cells 
Kouadio et al 2005; Kouadio et al, 
2007; Videmann et al 2008; Gao et 
al., 2016 
Ipec-1 
Wan et al, 2013b; Taranu et al, 
2014 
Ipec-J2 
Goossens et al, 2012; Wan et al., 
2013b 
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3.1 Introduction 
 
 Mycotoxins, secondary metabolites produced by moulds, frequently occur in food 
and feed (Oswald et al 2005; Schoelleberger et al., 2007) and a worldwide contamination 
is related to Fusarium mycotoxins (Scott, 1997; Placinta et al., 1999; Schollenberger et al.,  
2007; Lombaert et al., 2003).  
Fusarium mycotoxins can be classified in two groups: i) the “traditional” mycotoxins 
including fumonisins, trichothecenes and zearalenone (ZEA) and ii) the so-called 
“emerging” mycotoxins such as beauvericin (BEA), fusaproliferin, enniatins (ENNs) and 
moniliformin (Jestoi, 2008). 
Among the fumonisins, fumonisin B1 (FB1) is considered the main toxin in terms of 
toxicity (Rodrigues and Naehrer, 2012) and its co-occurrence with other Fusarium 
mycotoxins is well established (EFSA, 2005; Voss et al., 2007). Leukoencephalomalacia 
in horses (Kellerman et al., 1990; Raymond et al., 2005), pulmonary edema in pigs 
(Harrison et al., 1990; Tiemann and Danick, 2007) and nephropathy in rabbits 
(Gumprecht et al., 1995; Wangikara et al., 2005)  are species-specific effects related to 
the exposure to FB1. Cattle seem less sensitive than other animals such as horses or pigs 
to FB1 (Osweiler et al., 1993; Mathur et al., 2001; Tiemann and Danick, 2007; Fink-
Gremmels, 2008).  
The complex mechanism of action of FB1 (Wang et al., 1991; Voss et al., 2002; Voss et 
al., 2007; Gbore et al., 2012) is based on the inhibition of ceramide synthase (Wang et al., 
1991; Voss et al., 2007; Luongo et al. 2008) with the alteration of the sphingolipid 
metabolism (Wang et al., 1991; Wang et al; 1992; Merrill et al., 2001; Marasas et al., 2004; 
Voss et al., 2007; Smith, 2012).  
In relation to reproductive effects, no data are available on cattle, while in vitro studies 
demonstrated that FB1 also combined with DON or α-ZEA, affects porcine granulosa 
cells (GC) (Cortinovis et al., 2014).  
Among trichothecenes, DON, also called vomitoxin for its emetic effects,  is one of the 
most important and widespread in cereal grains and animal feed (Rotter et al., 1996). The 
co-occurrence of DON with other mycotoxins such as ZEA is a common feature of 
several studies (Richard, 2007; Pinton and Oswald, 2014).  
Feed refusal was  observed in pigs and in cattle (Trenholm et al., 1984; Dersjant-Li et al., 
2003; Akande et al., 2006; Rodrigues and Naehrer, 2012) after exposure to DON.  
Reproductive disorders have also been reported in livestock (Diekman and Green, 
1992), but little is known about DON effects on ruminant reproduction (Seeling et al., 
2006). 
ZEA is a non-steroidal estrogenic Fusarium mycotoxin known to contaminate various 
crops, especially corn, wheat, barley and oats (Cheeke, 1998; Zinedine et al., 2007; 
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Ferrigo et al., 2016). ZEA is able to bind to cytosolic estrogen receptors in target cells 
(Riley and Norred, 1996) and acts like endocrine disruptor with estrogenic effects 
(Frizzell et al., 2011). Its activity is related to the transcription of estrogen-responsive 
genes and consequently to the modulation of the translation of new proteins and the 
expression of estrogenic effects upon the target cells (Parveen et al., 2009).  
The hyperstimulation of estrogen-dependent tissues is the main effect of ZEA exposure 
(Böhm and Razzai-Fazeli, 2005; Malekinejad et al., 2007). The α-ZEA metabolite seems 
to have an higher binding affinity to estrogen receptors compared to ZEA and β-ZEA 
metabolite (Fink-Gremmels, 2008).  
As reported for FB1, cattle are considered to be less susceptible than other domestic 
animals to the adverse effects of ZEA (Upadhaya et al., 2010). In rumen ZEA is 
converted into α-ZEA and β-ZEA (Abidin and Khatoon, 2012; Winkler et al., 2014) and 
the rate of absorption of the more polar α-ZEA is poor and hyprestrogenism is 
infrequently observed in cows. Study conducted on liver microsomes demonstrated that 
the ratio between α-ZEA and β-ZEA formation varies among animal species and that in 
ruminants, because ZEA undergoes hepatic metabolism, β-ZEA seems to prevail as 
results of hepatic metabolism, whereas α-ZEA is the most frequent metabolite in pigs 
(Malekinejad et al., 2007; Fink-Gremmels, 2008). ZEA and its metabolites exert their 
toxicity by binding to estrogens receptors and the clinical signs of hyperestrogenism in 
ruminants are generally observed after long-term exposure to ZEA and after ingestion of 
highly contaminated feed (Fink-Gremmels, 2008; Upadhaya et al., 2010). ZEA exposure 
has also been linked to infertility, reduction in milk production, inhibition of oocytes 
maturation to metaphase II and an alteration of steroidogenesis in cattle (Minervini and 
Dell’Aquila, 2008; Pizzo et al., 2016). 
BEA is a cyclic hexadepsipeptide that was first isolated from the culture of the soil-
borne entomopathogenic fungus Beauveria bassiana (Leslie and Summerell, 2006). BEA is 
also synthesized by several Fusarium spp. parasitic to important cereal grains including 
corn, wheat, rice and barley (Leslie and Summerell, 2006). High contamination levels, up 
to 500 mg/kg of BEA, detected in surveys carried out across Europe are raising serious 
concerns about the potential impact of BEA on animal and human health (Uhlig et al., 
2007; Jestoi, 2008). Few data are available on BEA toxicity so far (EFSA, 2014). BEA 
proved to exert potent cytotoxicity against several mammalian cell lines (Jestoi, 2008; 
Klarić et al, 2008; Ferrer et al, 2009; Ruiz et al., 2011; Prosperini et al., 2012; Mallebrera 
et al., 2016) and this effect seems to be related to its ionophoric properties (EFSA, 
2014). Accordingly, BEA is able to promote the transport of cations, such as calcium, 
through the membranes disturbing their normal physiological concentrations in the cell 
and thus affecting ionic homeostasis (Jestoi, 2008).  
To date information on the effects of FB1 alone or combined with other Fusarium 
mycotoxins on reproduction in cattle is lacking. 
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In the present study primary bovine GC, which are considered a reliable in vitro model 
for reproductive toxicological research (Petro et al., 2012), were used to evaluate the 
individual and combined effects of FB1 with DON, α-ZEA, β-ZEA and BEA on cell 
proliferation, steroid production and gene expression.  
 
 
3.2 Materials and methods 
 
3.2.1 Reagents and hormones 
 
 Reagents were: Dulbecco's Modified Eagle Medium (DMEM), Ham's F12, 
Fumonisin B1 (FB1), Deoxynivalenol (DON), α-Zearalenol (α-ZEA) β-Zearalenol (β-
ZEA) and Beauvericin (BEA) obtained from Sigma Chemical Co. (St. Louis, MO); fetal 
calf serum (FCS) obtained from Atlanta Biologicals (Flowery Branch, GA); purified 
ovine follicle stimulating hormone (FSH; FSH activity, 15 NIH-FSH-S1 U/mg) obtained 
from Dr. A. F. Parlow, National Hormone and Pituitary Program (Torrance, CA); 
recombinant human insulin-like growth factor 1 (IGF1) obtained from R&D Systems 
(Minneapolis, MN); and testosterone obtained from Steraloids (Wilton, NH). 
 
 
3.2.2.Cell culture 
 
 Ovaries from non-pregnant beef cows were collected from a slaughterhouse as 
previously described (Langhout et al., 1991; Lagaly et al., 2008). Based on surface 
diameter small follicles (1-5 mm) were aspirated (Fig. 3.1) and GC were recovered from 
follicular fluid by centrifugation (291 x g for 10 min). GC were washed three times with 7 
mL of serum-free medium and resuspended in 2 mL of enzyme containing medium (0.5 
mg/mL of DNase and 1.25 mg/mL of collagenase) to prevent clumping of cells as 
previously described (Spicer et al., 2002; Lagaly et al., 2008). Numbers of viable cells 
were determined using the trypan blue exclusion method (Langhout et al., 1991; Spicer 
et al., 1993; Tiemann et al., 2003). Viable cells (2.5 x 105 in 20-80 µL of medium) were 
plated in 24-well Falcon multiwell plates (Becton Dickinson, Lincoln Park, NJ, USA) in 
1 mL of basal medium composed of a mixture of 1:1 DMEM and Ham's F-12 
containing glutamine (2 mM), gentamicin (0.12 mM) and sodium bicarbonate (38.5 mM). 
Cultures were kept at 38.5 °C in a humidified 95% air and 5% CO2 environment and 
medium was changed every 24 h. To obtain an optimal attachment, cells were 
maintained in the presence of 10% FCS for the first 48 h of culture. After this time, GC 
were washed twice with serum-free medium (0.5 mL) and the various treatments applied 
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in serum-free medium containing 500 ng/mL of testosterone (as an estradiol precursor) 
for 48 h with a medium change after 24 h. 
 
 
 
Figure 3.1: Collection of granulosa cells from small bovine follicles (1-5 mm) via needle aspiration. 
 
 
 
3.2.3 Determination of GC numbers  
  
 Medium was collected from individual wells and frozen at -20 °C for subsequent 
steroid analyses. Numbers of GC, in the same wells from which medium was collected, 
were determined by a Coulter counter (model Z2; Beckman Coulter, Inc., Hialeah, FL) 
(Fig. 3.2) as previously described (Lagaly et al., 2008), and used to calculate steroid 
production on ng or pg per 105 cell basis. Briefly, cells were gently washed twice with 
0.9% saline solution (500 mL), exposed to 500 mL of trypsin (0.25% wt/vol; 2.5 
mg/mL) for 20 min at room temperature, and then scraped from each well and 
enumerated as previously described (Langhout et al., 1991; Lagaly et al., 2008).  
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Figure 3.2: Determination of granulosa cell numbers using a Z2 Coulter® Particle Count and Size Analyzer. 
 
 
3.2.4 Determination of steroid concentrations 
 
 Concentrations of progesterone (P4) and estradiol (E2) in culture medium were 
determined by radioimmunoassay (RIA) as previously described (Spicer and 
Chamberlain, 1998; Lagaly et al., 2008). The intra- and inter-assay coefficients of 
variation were 7% and 13%, respectively for the P4 RIA, and 8% and 17%, respectively 
for the E2 RIA. P4 production was evaluated because it, like E2 production, increases as 
GC undergo differentiation (Hsueh et al., 1984; Ainsworth et al., 1990). 
 
 
3.2.5 Progesterone RIA 
 
 Progesterone RIA were conducted using rabbit antiserum (X-16), which serves as 
the first antibody (diluted 1:3000 with assay buffer: PBS, EDTA, NaN3, and gelatin), 
raised against BSA-11 glutamate derivative as described by Baraño and Hammond 
(1985). Goat anti-rabbit antibody (diluted 1:15 with assay buffer) was used as the second 
antibody (Linco Research, Inc., St. Charles, MO). [125I]Iodo-progesterone (ICN 
Biomedicals, Costa Mesa, CA) was used as the tracer. A progesterone standard curve 
was prepared from a stock concentration of 80.0 ng/mL that was serially diluted with 
assay buffer to concentrations of 40.0, 20.0, 10.0, 5.0, 2.5, 1.25, 0.625, 0.31, and 0.16 
ng/mL. In duplicate, 20 µL to 100 µL of medium samples were combined with the 
appropriate volume of assay buffer to make a total volume of 100 µL. One hundred µL 
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of tracer and first antibody were added and all samples were mixed and allowed to 
incubate at 37 °C for 1 h. Following incubation, 200 µL of second antibody were added 
and all samples were incubated overnight at 4 °C. The following day, 50 µL of normal 
rabbit serum (NRS) (diluted 1:5 with assay buffer from a 15% NRS stock) were added to 
all samples. Samples were centrifuged at 4 °C in a Sorvall Model RC-3 (Thermo Fisher 
Scientific, Inc., Miami, OK) at 1800 x g for 25 min. Supernatant was aspirated and 
precipitates were counted for 1 min using a Cobra AII Auto-Gamma counter (Packard 
Instrument Co., Downers Grove, IL). The intra- and interassay coefficients of variation 
were 7 and 13%, respectively, for the progesterone RIA. 
 
 
3.2.6 Estradiol RIA 
 
 Estradiol RIA were conducted using anti-estradiol rabbit antibody (diluted 1:12 
with assay buffer), which serves as the first antibody (Lilly Research Laboratories, 
Indianapolis, IN), and goat anti-rabbit antibody (diluted 1:15 with assay buffer) which 
serves as the second antibody (Linco Research, Inc., St. Charles, MO). Radiolabeled 
estradiol (125I-estradiol) was used as the tracer (ICN Biomedicals, Costa Mesa, CA). The 
assay buffer was the same as the progesterone RIA buffer described above. An estradiol 
dose response curve was prepared from a stock concentration of 256 pg/100 µL that 
was serially diluted to 128, 64, 32, 16, 8, 4, 2, 1, and 0.5 pg/100 µL using assay buffer. In 
duplicate, sample media was added at either 50 or 100 µL and (if needed) combined with 
assay buffer to make a total volume of 100 µL. Two hundred µL of tracer were added to 
all samples, along with 100 µL of first antibody. All tubes were mixed and allowed to 
incubate for 1 h at 37 °C. Following this incubation, 200 µL of second antibody were 
added and the assay allowed to incubate at 4 °C overnight. The following day, assay 
tubes were centrifuged, supernatant aspirated, and precipitate counted as described for 
the progesterone RIA. The intra- and interassay coefficients of variation were 8% and 
17%, respectively, for the estradiol RIA. 
 
 
3.2.7 RNA extraction  
 
 At the end of the treatment period, cells from two replicate wells were lysed in 
500 µL of TRIzol® reagent and RNA was extracted as previously described (Voge et al., 
2004; Aad et al., 2006). Briefly, 250 µL TRIzol® reagent was added to all wells and cells 
were lysed by repeated pipetting and then combined with their respective replicates. 
Combined wells were then transferred to 1.5 mL eppendorf tubes. Each treatment 
containing 4 wells generated 2 replicate samples of RNA. Cell lysates were incubated in 
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TRIzol® reagent for approximately 5 min at room temperature, then 100 µL of 
chloroform was added to each sample followed by a 15 s vortex. After approximately a 2 
min incubation at room temperature, samples were centrifuged at 3500 x g for 30 min at 
4 °C using eppendorf centrifuge 5417C (Brinkmann Instruments, Westbury, NY). The 
upper aqueous phase of each sample was then transferred to a fresh eppendorf tube and 
RNA was precipitated using 250 µL isopropanol. Samples were incubated at room 
temperature for 10 min and then centrifuged at 3500 x g for 10 min at 4 °C. The RNA 
pellets were washed after discarding the supernatant with 500 µL of 70% ethanol and 
allowed to dry at room temperature. The RNA pellets were suspended in 16.5 µL of 
DEPC-treated water. RNA was quantitated by spectrophotmetry at 260 nm using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). 
Aliquots of 1.5 µL of RNA were used to determine the concentration in ng/µL as well 
as the purity given as a ratio of 260/280 nm where values between 1.8 and 2.2 were 
acceptable. RNA was then diluted to 10 ng/µL in DEPC-treated water and stored at -80 
°C until used for quantification of target gene expression. Just prior to use, an RNA 
aliquot was thawed on ice for 3-5 min. 
 
 
3.2.8 Real-time PCR  
 
 The target gene primers (forward, reverse) and probe sequences for bovine 
aromatase enzyme (CYP19A1; Accession NM_174305) were 
TGCCAAGAATGTTCCTTACAGGTA, CAGAGTGACCTTCATCATGACCAT and 
CATTTGGCTTTGGGCCCCGG, respectively; and for bovine P450 side-chain 
cleavage enzyme (CYP11A1; Accession NM_176644) were 
CTCCGTGACCCTGCAGAGATAC, ATAGACGGCCACTTGTACCAATG and 
TTGGTTCTTCGAGATTACATGATTCCTGCC, respectively (Lagaly et al., 2008; 
Spicer and Aad, 2007). The differential expression of target gene mRNA in GC was 
quantified using the one-step multiplex real-time RT-PCR reaction for Taqman® Gold 
RT-PCR Kit (Applied Biosystems, Foster City, CA) as previously described (Spicer and 
Aad, 2007). All samples were run in duplicate. The 18S ribosomal RNA values were used 
as internal controls to normalize samples for any variation in amounts of RNA loaded, 
and relative quantification of target gene mRNAs was expressed using the comparative 
threshold cycle method as previously described (Voge et al., 2004; Aad et al., 2006). 
Briefly, the ΔCt was determined by subtracting the 18S Ct value from the target 
unknown value. For each target gene, the ΔΔCt was determined by subtracting the 
higher ΔCt (the least expressed unknown) from all other ΔCt values. Fold changes in 
target gene mRNA abundance were calculated as being equal to 2 -ΔΔCt. 
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3.2.9 Experimental design 
 
 Experiment 1 was performed to evaluate the effects of FB1 alone and combined 
with β-ZEA on GC proliferation and steroidogenesis. Cells were cultured for 48 h in 
10% FCS, washed twice with serum-free medium as described earlier, and then treated 
for 48 h in serum-free medium containing testosterone (500 ng/mL), FSH (30 ng/mL) 
and IGF1 (30 ng/mL) with or without FB1 at 0, 30, 100 ng/mL (0; 0.042; 0.13 µM) and 
β-ZEA  at 0 or 30 ng/mL (0; 0.094 µM). After 48 h of treatment, cells were counted and 
medium was collected for E2 and P4 RIA. Doses of FSH and IGF1 were selected based 
on previous studies (Spicer et al., 2002; Ranzenigo et al., 2008). Because IGF1 alone has 
little or no effect on steroid production, FSH was added to all treatments (Spicer et al., 
1993; 2002; Ranzenigo et al., 2008). 
Experiment 2 was designed to evaluate the effects of interaction between FB1, DON 
and DON with β-ZEA. GC were cultured for 48 h in 10% FCS  washed twice with 
serum-free medium as described earlier, and cells treated for 48 h in serum-free medium 
containing 500 ng/mL of testosterone, 30 ng/mL of FSH and 30 ng/mL of IGF1with 
FB1 at 0, 30, 100 ng/mL (0; 0.042; 0.13 µM), DON at 0 or 100 ng/mL (0; 0.33 µM) and 
β-ZEA at 0 or 30 ng/mL (0; 0.094 µM). After 48 h of treatment, medium was collected 
for P4 and E2 RIA, and cells were counted. 
Experiment 3 was performed to evaluate the effects of FB1 alone and combined with   
α-ZEA and β-ZEA in the presence of FSH and with or without IGF1 on GC 
proliferation and steroidogenesis. Cells were cultured for 48 h in 10% FCS, washed twice 
with serum-free medium as described earlier, and cells treated for 48 h in serum-free 
medium containing testosterone (500 ng/mL), FSH (30 ng/mL) with or without IGF1 
(30 ng/mL). FB1 was tested at 5 µg/mL (6.9  µM) alone and combined with α-ZEA at 5 
µg/mL (15.6  µM) and β-ZEA at the same concentration (15.6  µM). After 48 h cells 
were counted and medium was collected for P4 and E2 RIA. 
Experiment 4 was carried out to compare the dose response of FB1 and BEA on FSH 
plus IGF1–induced GC proliferation and steroidogenesis. GC were cultured for 48 h in 
10% FCS washed twice with serum-free medium as described earlier, and cells treated 
for 48 h in serum-free medium containing testosterone (500 ng/mL), FSH (30 ng/mL) 
and IGF1 (30 ng/mL) with the various doses of FB1 (i.e., 0, 0.3, 1, 3, 10 µM) or BEA (0, 
0.3, 1, 3, 10 µM). After 48 h of treatment, medium was collected for determination of 
progesterone and estradiol concentrations via RIA, and cells were counted. Doses of 
FSH and IGF1 were selected based on previous studies (Spicer et al., 2002; Ranzenigo et 
al., 2008). Because IGF1 alone has little or no effect on steroid production, FSH was 
added to all treatments (Spicer et al., 1993; 2002; Ranzenigo et al., 2008). 
Experiment 5 was performed to evaluate the effects of FB1 and BEA, alone and in 
combination, on GC proliferation and steroidogenesis. Cells were cultured for 48 h in 
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10% FCS, washed twice with serum-free medium as described earlier, and cells treated 
for 48 h in serum-free medium containing testosterone (500 ng/mL), FSH (30 ng/mL) 
and IGF1 (30 ng/mL) with or without FB1 (3 µM) and BEA (3 µM). After 48 h of 
treatment, cells were counted and medium was collected for determination of 
progesterone and estradiol concentrations via RIA. 
Experiment 6 was designed to evaluate the dose response of FB1 alone and combined 
with BEA on GC proliferation and steroidogenesis. Cells were cultured for 48 h in 10% 
FCS, washed twice with serum-free medium, and then treated for 48 h in serum-free 
medium containing testosterone (500 ng/mL), FSH (30 ng/mL) and IGF1 (30 ng/mL) 
with the various doses of FB1 (i.e., 0, 0.5, 1, 1.5, 3, or 6 µM) with or without BEA (3 
µM). After 48 h of treatment, medium was collected for determination of progesterone 
and estradiol concentrations via RIA, and cells were counted. 
Experiment 7 was designed to determine the dose response of BEA alone and combined 
with FB1 on GC proliferation and steroidogenesis. Cells were cultured for 48 h in 10% 
FCS, washed twice with serum-free medium, and then treated for 48 h in serum-free 
medium containing FSH (30 ng/mL) and IGF1 (30 ng/mL) with the various doses of 
BEA (i.e., 0, 0.5, 1, 1.5, 3, or 6 µM) with or without FB1 (3 µM). After 48 h of treatment, 
medium was collected for determination of progesterone and estradiol concentrations 
via RIA, and cells were counted. 
Experiment 8 was performed to determine the effects of FB1 and BEA on CYP11A1 
and CYP19A1 mRNA abundance. Cells were cultured for 48 h in 10% FCS, washed 
twice with serum-free medium as described earlier, and cells treated for 24 h in serum-
free medium containing testosterone (500 ng/mL), FSH (30 ng/mL), IGF1 (0 or 30 
ng/mL) and FB1 (30 µM) or BEA (30 µM). After 24 h of treatment, medium was 
aspirated and cells were lysed for RNA extraction. 
Experiment 9 was carried out to determine the effect of FB1 and BEA on serum-
stimulated GC proliferation. Cells were cultured for 4 days in 10% FCS. During the last 
2 days of culture, cells were treated as follows: control (no additions), FB1 (10 μM) or 
BEA (10 μM). At the end of treatment, cells were counted. 
 
 
3.2.10 Statistical analysis 
 
 Experimental data are presented as the least squares means ± SEM of 
measurements from replicated experiments (n=3) with each treatment applied in 
triplicate or duplicate wells for each replicate experiment. Each replicated experiment 
was derived from a different pool of GC generated from a total volume of 10 mL 
follicular fluid obtained from twenty to thirty ovaries. For mRNA experiments, 
treatments were applied in quadruplicate culture wells with each mRNA sample being 
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obtained from two wells. Treatment effects were assessed by factorial ANOVA designs 
in the GLM procedure of the Statistical Analysis System (SAS) using SAS for Windows 
(version 9.2, SAS Institute Inc., Cary, NC). Steroid production was expressed as ng or 
pg/105 cells per 24 h, and GC numbers determined at the end of the experiment were 
used for this calculation. A P-value of less than 0.05 was considered statistically 
significant. Mean differences in steroid production, cell numbers and mRNA abundance 
between treatments were determined using the Fisher's protected least significant 
difference (LSD) procedure (Ott, 1977). 
 
 
 
3.3 Results 
 
3.3.1 Experiment 1: Dose response of FB1 alone and combined with β-ZEA on GC numbers and 
steroid production in the presence of FSH with IGF1 
 
The results revealed that FB1 alone at 30 and 100 ng/mL (0; 0.042; 0.13 µM) had 
no effect (P>0.10) on GC numbers. In the presence of β-ZEA at 30 ng/mL (0.094 µM), 
FB1 at 30 ng/mL (0.042 µM) showed a stimulatory effect (P<0.05) on GC numbers (Fig. 
3.3),  whereas FB1 at 100 ng/mL (0.013 µM) increased (P<0.05) P4 production (Fig. 
3.4). FB1 at 30 ng/mL (0.042 µM) and 100 ng/mL (0.13 µM) was found to amplify the 
inhibitory effect of β-ZEA at 30 ng/mL (0.094 µM) on E2 production (Fig. 3.5). 
 
 
Figure 3.3: Effect of FB1 on numbers of GC from bovine follicles. Means (± SEM) without a common letter 
(a–c) differ (P < 0.05). FB1, fumonisin B1; β-ZEA, β-zearalenone; SEM, standard error of the mean. 
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Figure 3.4: Effect of FB1 on progesterone production of GC from bovine follicles. Means (± SEM) without a 
common letter (a–b) differ (P < 0.05). FB1, fumonisin B1; β-ZEA, β-zearalenone; SEM, standard error of the 
mean. 
 
 
 
Figure 3.5: Effect of FB1 on estradiol production of GC from bovine follicles. Means (± SEM) without a 
common letter (a–c) differ (P < 0.05). FB1, fumonisin B1; β-ZEA , β-zearalenone;, SEM, standard error of the 
mean. 
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3.3.2 Experiment 2: Dose response of FB1 alone and combined with DON and β-ZEA on GC 
numbers and steroid production in the presence of FSH with IGF1 
 
 No significant interaction (P>0.10) existed between FB1 at 30 ng/mL and 100 
ng/mL (0; 0.042; 0.13 µM) and DON at 100 ng/mL (0.33 µM) or between FB1 at 30 
ng/mL and 100 ng/mL (0; 0.042; 0.13 µM) and the combination of β-ZEA  at 30 
ng/mL (0.094  µM) and DON  at100 ng/mL (0.33 µM) on cell numbers (Fig. 3.6). 
Regarding P4 and E2 production, no significant interaction (P>0.10) was observed 
between FB1 at 30 ng/mL and 100 ng/mL (0; 0.042; 0.13 µM) and DON at 100 ng/mL  
(0.33 µM ) alone or with β-ZEA  at 30 ng/mL  (0.094  µM) on P4 (Fig. 3.7) or E2 (Fig. 
3.8) production, but β-ZEA inhibited (P<0.05) P4 production in DON treated GC (Fig. 
3.7). 
 
 
Figure 3.6: Interaction between FB1 and DON or β-ZEA on proliferation of bovine GC. Values are means ± 
SEM from three separate experiments. Means without a common letter (a) differ (P < 0.05). FB1, fumonisin B1; 
DON, deoxynivalenol; β-ZEA, β-zearalenone; SEM, standard error of the mean. 
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Figure 3.7: Interaction between FB1 and DON or β-ZEA on progesterone production by GC from bovine 
follicles. Values are means ±SEM from three separate experiments. Means without a common letter (a–b) differ 
(P < 0.05). DON, deoxynivalenol; FB1, fumonisin B1;  β-ZEA , β-zearalenone; SEM, standard error of the mean. 
 
 
Figure 3.8: interaction between FB1 and DON or β-ZEA on estradiol production by GC from bovine follicles. 
Values are means ±SEM from three separate experiments. Means without a common letter (a) differ (P < 0.05). 
DON, deoxynivalenol; FB1, fumonisin B1; β-ZEA , β-zearalenone; SEM, standard error of the mean. 
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3.3.3 Experiment 3: Effect of FB1 alone and combined with either  α-ZEA  or  β-ZEA  on GC 
numbers and steroid production 
 
Experiment 3 was conducted to assess the effects of FB1 alone and combined 
with α-ZEA  and β-ZEA  on cell proliferation and steroidogenesis with and without 
IGF1. In the absence of IGF1, GC numbers (Fig. 3.9), P4 production (Fig. 3.10), and 
E2 production (Fig. 3.11) were not affected by any of the mycotoxins or their 
combinations. IGF1 induced (P<0.05) GC proliferation and this increase was blocked (P 
< 0.05) after exposure to β-ZEA alone and FB1 with either α-ZEA or β-ZEA (Fig. 3.9). 
In contrast, IGF1-induced P4 production was not affected (P>0.10) by FB1, α-ZEA , β-
ZEA or their combinations (Fig. 3.10). However, IGF1-induced E2 production was 
increased (P<0.05) with FB1 alone (Fig. 3.11). In contrast, α-ZEA alone, β-ZEA alone, 
or their combination with FB1 decreased (P<0.05) IGF1-induced E2 production (Fig. 
3.11). 
 
 
 
Figure 3.9: Effect of FB1 on numbers of GC from bovine follicles. Values are means ± SEM from three 
separate experiments.  Means without a common letter (a–e) differ (P < 0.05). FB1, fumonisin B1; α-ZEA,  α–
zearalenone; β-ZEA , β-zearalenone; SEM, standard error of the mean. 
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Figure 3.10: Interaction between FB1, α-ZEA or β-ZEA on progesterone production of bovine GC. Values are 
means ± SEM from three separate experiments. Means without a common letter (a-f) differ (P < 0.05).  FB1, 
fumonisin B1; α-ZEA, α-Zearalenone;, β-ZEA, β-Zearalenone, SEM, standard error of the mean. 
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Figure 3.11: Interaction between FB1, α-ZEA or β-ZEA on estradiol production of bovine GC. Values are 
means ± SEM from three separate experiments. Means without a common letter (a-e) differ (P < 0.05). FB1, 
fumonisin B1; α-ZEA, α-Zearalenone;, β-ZEA, β-Zearalenone, SEM, standard error of the mean.  
 
 
 
3.3.4 Experiment 4: Dose response of FB1 and BEA on GC numbers and steroid production in the 
presence of FSH plus IGF1 
 
 Cell proliferation was not affected (P ≥ 0.05) by any dose of FB1 (i.e., 0.3, 1, 3, 10 
µM), whereas BEA at the highest dose tested (10 µM) decreased (72%; P < 0.01) cell 
numbers (Fig. 3.12). FB1 at all doses did not significantly affect progesterone production, 
whereas BEA at 3 and 10 µM strongly inhibited (P < 0.0001) progesterone production 
(Fig. 3.13). Estradiol production was inhibited (P < 0.05) by 25% and by 57% after 
exposure to FB1 at 10 µM and BEA at 3 µM, respectively (Fig. 3.14).   
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Figure 3.12: Effect of FB1 and BEA on FSH plus IGF1–induced proliferation of bovine GC. Values are means 
± SEM from three separate experiments. Means without a common letter (a–d) differ (P < 0.05). BEA, 
beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
 
 
Figure 3.13: Effect of FB1 and BEA on FSH plus IGF1-induced progesterone production by GC from bovine 
follicles. Values are means ± SEM from three separate experiments.  Means without a common letter (a–d) differ 
(P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
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Figure 3.14: Effect of FB1 and BEA on FSH plus IGF1-induced estradiol production by GC from bovine 
follicles. Values are means ± SEM from three separate experiments.  Means without a common letter (a–d) differ 
(P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
3.3.5 Experiment 5: Individual and combined effects of FB1 and BEA on GC numbers and steroid 
production in the presence of FSH plus IGF1 
 
 BEA (3 µM) significantly inhibited (P< 0.0001) cell proliferation and progesterone 
and estradiol production by 54%, 97% and 80%, respectively (Fig. 3.15, 3.16, 3.17). FB1 
(3 µM) did not affect (P > 0.05) any of the variables measured and did not influence the 
effect of BEA on cell proliferation (Fig. 3.15)or steroid production (Fig. 3.16, 3.17). 
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Figure 3.15: Interaction between FB1 and BEA on FSH plus IGF1–induced proliferation of bovine GC. Values 
are means ± SEM from three separate experiments. Means without a common letter (a–b) differ (P < 0.05). 
BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
 
Figure 3.16: Interaction between FB1 and BEA on FSH plus IGF1-induced progesterone production by GC 
from bovine follicles. Values are means ± SEM from three separate experiments. Means without a common 
letter (a–b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
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Figure 3.17: Interaction between FB1 and BEA on FSH plus IGF1-induced estradiol production by GC from 
bovine follicles. Values are means ± SEM from three separate experiments. Means without a common letter (a–
b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
3.3.6 Experiment 6: Dose response of FB1 with or without BEA on FSH plus IGF1-induced GC 
proliferation and steroid production 
 
 Cell proliferation was not affected (P ≥ 0.05) after exposure to FB1 at 0.5, 1, 1.5 
and 3 µM alone or in combination with BEA (3 µM), whereas at the highest dose tested 
(6 µM) FB1 in combination with BEA decreased (P < 0.05) cell numbers (Fig. 3.18).  FB1 
alone had no significant effect (P > 0.05) on progesterone production (Fig. 3.19) 
whereas at 1 and 1.5 µM FB1 decreased (P < 0.05) estradiol production (Fig. 3.20). BEA 
at 3 µM drastically inhibited both progesterone (88%; P < 0.001) and estradiol (96%; P 
< 0.0001) production, and the various doses of FB1 did not influence these inhibitory 
effects (Fig. 3.19, 3.20). 
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Figure 3.18: Effect of various doses of FB1 with or without BEA on FSH plus IGF1-induced proliferation of 
bovine GC. Values are means ± SEM from three separate experiments. Means without a common letter (a–c) 
differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
 
Figure 3.19: Effect of various doses of FB1 with or without BEA on FSH plus IGF1-induced progesterone 
production by GC from bovine follicles. Values are means ± SEM from three separate experiments. Means 
without a common letter (a–b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
66 
 
 
Figure 3.20: Effect of various doses of FB1 with or without BEA on FSH plus IGF1-induced estradiol 
production by GC from bovine follicles. Values are means ± SEM from three separate experiments. Means 
without a common letter (a–b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells 
 
 
  
3.3.7 Experiment 7: Dose response of BEA with or without FB1 on FSH plus IGF1-induced GC 
proliferation and steroid production 
 
 At the highest dose tested (6 µM), BEA was found to inhibit (50%; P < 0.05) cell 
proliferation and no significant difference was detected in combination with FB1 (3 µM) 
(Fig. 3.21). BEA at 3 and 6 µM was found to strongly decrease (P < 0.05) both 
progesterone and estradiol production, and FB1 had little effect on these responses (Fig. 
3.22, 3.23). FB1 had no effect (P > 0.05) on progesterone production (Fig. 3.22) but at 3 
µM FB1 decreased (P < 0.05) estradiol production alone and in combination with 1 µM 
BEA (Fig. 3.23). 
 
 
67 
 
 
Figure 3.21: Effect of various doses of BEA with or without FB1 on FSH plus IGF1–induced proliferation of 
bovine GC. Values are means ± SEM from three separate experiments. Means without a common letter (a–c) 
differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
 
Figure 3.22: Effect of various doses of BEA with or without FB1 on FSH plus IGF1-induced progesterone 
production by GC from bovine follicles. Values are means ± SEM from three separate experiments. Means 
without a common letter (a–e) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
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Figure 3.23: Effect of various doses of BEA with or without FB1 on FSH plus IGF1-induced estradiol 
production by GC from bovine follicles. Values are means ± SEM from three separate experiments. Means 
without a common letter (a–e) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
3.3.8 Experiment 8: Effect of FB1 and BEA on GC CYP11A1 and CYP19A1 mRNA 
 
 BEA (30 µM) showed an inhibitory effect on FSH plus IGF1-induced CYP11A1 
and CYP19A1 mRNA abundances (P < 0.05), whereas FB1 (30 µM) had no effect on 
gene expression (Fig. 3.24, 3.25).  
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Figure 3.24: Effect of BEA and FB1 on FSH plus IGF1-induced CYP11A1 mRNA abundance in GC from 
bovine follicles. Values are means ± SEM from three separate experiments. Means without a common letter (a–
b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
 
 
 
Figure 3.25: Effect of BEA and FB1 on FSH plus IGF1-induced CYP19A1 mRNA abundance in GC from 
bovine follicles. Values are means ± SEM from three separate experiments. Means without a common letter (a–
b) differ (P < 0.05). BEA, beauvericin; FB1, fumonisin B1; GC, granulosa cells. 
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3.3.9 Experiment 9: Effect of FB1 and BEA on serum-induced GC proliferation 
 
 Both FB1 (10 μM) and BEA (10 μM) decreased (P < 0.001) GC proliferation 
induced by 10% FCS (Fig. 3.26). Cell numbers were decreased (P < 0.001) by 31% after 
1 day of BEA treatment and by 88% and 15% after 2 days of BEA and FB1 treatment, 
respectively (Fig. 3.26). 
 
 
Figure 3.26: Effect of FB1 and BEA on serum-induced proliferation of bovine GC. Within day of treatment, * 
indicates mean differs (P < 0.001) from control value. Values are means ± SEM from three separate 
experiments. BEA, beauvericin; FB1, fumonisin B1. 
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3.4 Discussion 
 
 GC function is fundamental for normal folliculogenesis and oocyte growth and 
development (Spicer et al., 2001; Petro et al., 2012; Rawan et al., 2015). Previous in vitro 
studies with Fusarium mycotoxins such as DON and ZEA demonstrated that these 
mycotoxins are able to directly affect GC proliferation and steroid production and 
consequently the follicle development and oocyte function in different species, such as 
pigs (Ranzenigo et al., 2008; Caloni et al., 2009; Cortinovis et al., 2014) and cattle (Pizzo 
et al., 2016). Ruminants are considered more resistant to FB1 than other species such as 
pigs and horses (Fink-Gremmels, 2008), but information on reproductive effects is 
lacking. The purpose of this study was to evaluate the in vitro toxicity of FB1 using a 
bovine GC model.  
Because the co-occurrence of Fusarium mycotoxins in commodities and their 
toxicological interaction have been demonstrated (Boutigny et al., 2012; Rodrigues and 
Naehrer, 2012), the combination of FB1 with DON, α-ZEA, β-ZEA and BEA was also 
evaluated. In this study the results show that FB1 alone at all the concentrations tested 
(0.042-10 µM) did not affect IGF1-induced GC proliferation. Differently, FB1  at 30 
ng/mL (0.042 µM) in combination with β-ZEA at 30 ng/mL (0.094 µM) (Fig. 3.3), had a 
stimulatory effect on GC numbers in the presence of IGF1, while β-ZEA alone at 30 
ng/mL (0.094 µM) had no effect on cell proliferation (Fig. 3.3). FB1 at 5 µg/mL (6.9 
µM) in combination with β-ZEA at 5 µg/mL (15.6 µM) inhibited IGF1-induced cell 
proliferation (Fig. 3.9), but this effect was also observed with β-ZEA alone (15.6 µM) 
(Fig. 3.9), and is in agreement with a previous study conducted on porcine GC (Tiemann 
et al., 2003). In accordance with previous studies (Ranzenigo et al., 2008; Pizzo et al., 
2016), α-ZEA and FB1 alone had not effect on GC proliferation, while co-exposure of 
FB1 (6.9 µM) and α-ZEA (15.6 µM) decreased IGF1-induced cell proliferation (Fig. 3.9), 
indicating that these two mycotoxins may interact inducing an inhibition of cell 
proliferation. 
Exposure of bovine GC to DON alone or combined with FB1 had no effect on cell 
proliferation, whereas previous studies conducted on porcine GC reported conflicting 
results on DON activity, showing either an inhibitory effect (Ranzenigo et al., 2008) or a 
stimulatory effect (Medvedova et al., 2011) depending on the dose of DON and the 
presence of α-ZEA. All these results suggest that the effects of FB1, DON, β-ZEA and 
α-ZEA on GC proliferation may be species-specific and influenced by their interaction.  
In the present study, the effect of BEA on GC proliferation was investigated for the first 
time. At concentrations ≥ 6 µM (Fig. 3.21), BEA was found to inhibit GC proliferation 
confirming results previously reported for other cell types (Jestoi, 2008). According  to 
previous studies (Klarić et al., 2008; Ferrer et al., 2009; Ruiz et al.,  2011; Prosperini et 
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al., 2012; Mallebrera et al., 2016) BEA exhibits potent cytotoxicity against several 
mammalian cell lines. In details, BEA was found to reduce cell viability in a time and 
concentration-dependent manner in Vero cells, CHO-K1 cells and Caco-2 cells at 6.25 
to 10.02 (Ruiz et al.,  2011), 5 µM (Mallebrera et al., 2016) and at 3.125 to 25 μM 
(Prosperini et al., 2012), respectively. 
The present study evaluated also the effects of Fusarium mycotoxins on GC 
steroidogenesis. FB1 alone at all the concentrations tested did not affect GC P4 
production. On the contrary, when combined with β-ZEA at 30 ng/mL (0.094 µM) and 
DON at 100 ng/mL (0.33 µM) plus β-ZEA at 30 ng/mL (0.094 µM), FB1 at 100 ng/mL 
(0.13 µM) stimulated and inhibited P4 production, respectively.   
The lack of an effect of FB1 on P4 production is also supported by the results showing 
no effect of FB1 on CYP11A1 mRNA abundance in GC.  Differently BEA was found to 
inhibit P4 production and this effect was associated with a significant suppression of 
CYP11A1 mRNA abundance, suggesting that BEA may alter P4 production via a 
change in CYP11A1 mRNA abundance. 
As regards E2 production, in this study FB1 at 30 (0.042 µM) and 100 ng/mL (0.13 µM) 
did not affect E2 production (Fig. 3.5), but at 5 µg/mL (6.9 µM) increased E2 
production (Fig. 3.11), whereas, at the same concentration (i.e., 5 µg/mL corresponding 
to 6.9 µM ) both α-ZEA and β-ZEA alone inhibited E2 production (Fig. 3.11). The 
combination of FB1 at 5 µg/mL (6.9 µM) with α-ZEA at 5 µg/mL (15.6 µM) and β-ZEA 
at 5 µg/mL (15.6 µM) confirms the inhibition of E2 production induced by these two 
ZEA metabolites (Fig. 3.11). Indeed, FB1 combined with α-ZEA at 5 µg/mL (15.6 µM) 
had no effect on E2 production, whereas in combination with β-ZEA at 5 µg/mL (15.6 
µM) an inhibitory effect on E2 release was observed. It is well established that estrogenic 
α-ZEA and β-ZEA effects are mediated by binding to intracellular estrogen receptors 
(Parveen et al., 2009). The inhibition on E2 production of ZEA major metabolites, 
clearly highlighted as a result of co-exposure with FB1, suggests an interference on 
aromatase activity. FB1 at 30 ng/ml (0.042 µM) and 100 ng/mL (0.13 µM) either with or 
without β-ZEA had no effect on the inhibition of E2 production induced by DON at 
100 ng/mL (0.33 µM) (Fig. 3.8), an effect previously  reported (Pizzo et al., 2016). The 
BEA-induced marked inhibition of E2 production by GC was associated with a 
significant decrease in CYP19A1 mRNA abundance, suggesting that BEA may alter E2 
production via suppression of CYP19A1 mRNA abundance. Previous studies 
demonstrated a role of CART (cocaine and amphetamine regulated transcript system) 
system on the regulation of bovine GC E2 production (Kobayashi et al., 2006; Lv et al., 
2009). This effect was linked to the inhibition induced by CART on several components 
of the FSH signal transduction pathway (Lv et al., 2009) that, since FSH stimulates E2 
production, may explain the negative effects of CART observed on bovine GC (Lv et al., 
2009). This mechanism of action could be involved for the inhibitory effects of BEA on 
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E2 production and GC CYP19A1 mRNA levels observed in the present study. BEA 
was found to reversibly inhibit L-type calcium channels in a dose-dependent manner in a 
neuronal cell line (Wu, 2002) and FSH-induced increase in GC calcium uptake is 
mediated via inhibition of L-type calcium channel activity (Peters et al., 2004; Kobayashi 
et al., 2006), but whether blockade of calcium channels is involved in BEA-induced 
inhibition of E2 production will require further study. 
 
The present study has been carried out with FB1 alone and in co-exposure firstly with 
DON and ZEA metabolites (α-ZEA and β-ZEA) and secondly with BEA, an emerging 
mycotoxin, demonstrating effects on cell proliferation and steroidogenesis using a 
bovine GC in vitro model, suggesting possible reproductive effects of these mycotoxins 
in cattle. 
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4. Effects of fumonisin B1 alone and combined with 
beauvericin on Caco-2 in vitro intestinal model  
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4.1 Introduction 
 
Mycotoxins are secondary metabolites produced by molds, such as Aspergillus, 
Fusarium and Penicillium (Osweiler, 2000). Fusarium mycotoxins are world-spread 
mycotoxins naturally occurring in cereals (Jurjevic, 2002; Logrieco et al., 2003; Domijan 
et al., 2005; Molinié et al., 2005; Ferrigo et al., 2016) and animal and human exposure is 
well established (Diekman and Green 1992; Binder et al., 2007; Fink-Gremmels, 1999; 
Prosperini, et al., 2012; Wu et al., 2014; EFSA 2014). 
Fumonisins are a group of mycotoxins mainly produced by Fusarium verticillioides, 
Fusarium proliferatum, Fusarium napiforme and Fusarium nygamai that have been shown to 
occur worldwide primarily in corn (Glenn, 2007; Voss et al., 2007).  
The most important group of fumonisins is the B series including fumonisin B1 (FB1), B2 
(FB2) and B3 (FB3) (EFSA 2005). In 2002 the IARC classified FB1 as possibly 
carcinogenic to humans (group 2B) (IARC, 2002; Santini et  al., 2015; Hove et al., 2016) 
and several studies reported that FB1 is associated with an increased prevalence of 
esophageal cancer in humans (Marasas et al., 1988; Sydenham et al. 1990; Rheder et al., 
1992; Hove et al., 2016).  
The complex mechanism of action of FB1 is based on the inhibition of sphingosine 
(sphinganine) N-acetyltransferase (ceramide synthase) (Wang et al., 1991; Voss et al., 
2002, 2007; Luongo et al. 2008; Gbore et al., 2012) with the consequent alteration of the 
sphingolipid metabolism (Wang et al., 1991; Wang et al; 1992; Merrill Jr. et al., 2001; 
Marasas et al., 2004; Voss et al., 2007; Smith, 2012). Specifically FB1, structurally similar 
to sphingoid bases, inhibits ceramide synthase and thus disrupts the de novo biosynthesis 
of ceramide and sphingolipid metabolism (Wang et al., 1991). FB1 is a competitive 
inhibitor with respect to both substrates of ceramide synthase (Merril Jr. et al., 2001; 
Marasas et al., 2004; Voss et al., 2007). This leads to the blockage of complex 
sphingolipid biosynthesis, essential for cell regulation, and to the accumulation of 
sphinganine, and, to a lesser degree, sphingosine (Wang et al., 1992; Merril Jr. et al., 
2001; Marasas et al., 2004; Smith, 2012). 
Fumonisins have been found to commonly occur in cereal grains and animal feed in 
combination with other Fusarium mycotoxins including beauvericin (BEA), a so-called 
emerging mycotoxin (Jestoi, 2008;  EFSA, 2014). 
BEA is a ionophoric molecule that can form lipophilic complexes with cations and 
transport them into biological membranes altering cell homeostasis (Hilgenfeld and 
Saenger, 1982; Jestoi et al., 2008; Prosperini et al., 2012; Fernandez-Blanco et al., 2016). 
In fact, it is well-known that an increase in the intracellular concentration of cations such 
as calcium and the subsequent activation of calcium-dependent endonucleases lead to 
DNA fragmentation which is involved in apoptosis (Speijers and Speijers, 2004; 
Kouadio et al., 2007). 
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Recent studies reported the in vitro adverse effects of BEA on human, porcine and 
rodent cell lines (Jestoi, 2008;  Prosperini et al., 2012; Fernandez Blanco et al., 2016; 
Mallebrera et al., 2016). Schoevers et al. (2016) studied the effects of BEA on porcine 
cumulus cells, oocytes and embryos. In this study the cumulus-oocyte-complexes and 
developing embryos were exposed to BEA at concentrations ranging from 0.31 to 10 
μM and the effects of this mycotoxin on viability, progesterone synthesis and apoptosis 
were evaluated (Schoevers et al., 2016). Schoevers et al. (2016) demonstrated that BEA 
reduced the developmental competence of both the maturing oocytes and the two-four 
cell stage embryos in pigs, and that BEA only affected the rate of developing embryos at 
concentrations exceeding 0.5 μM. BEA toxic effects on human cell lines were 
investigated by Prosperini et al. (2012). The authors evaluated the cytotoxicity of BEA 
on human Caco-2 cells testing concentrations ranging from 0.6 to 30 μM. The IC50 
obtained for BEA was 20.62 ± 6.9 μM at 24 h of exposure and 12.75 ± 4.8 at 48 h 
(Prosperini et al., 2012).  
Recently, exposure of Caco-2 cells to 0.001–10 μM BEA showed that BEA at 1 μM and 
10 μM had cytotoxic effects on Caco-2 cells (Fernandez-Blanco et al., 2016). 
The in vitro absorption and toxicity of FB1 have been investigated with different intestinal 
models (Caloni et al., 2002; Bouhet et al., 2004; De Angelis et al., 2005; Loiseau et al., 
2007; Ulluwishewa et al., 2011; Minervini et al., 2014; Romero et al., 2016; Wentzel et al., 
2016). In vitro studies with Caco-2 cell monolayers (Caloni et al., 2002) demonstrated low 
toxicity of FB1 and its metabolites after 48 h of exposure to concentrations ranging from 
1 to 138 μM, even though FB1 appeared to be the most active. The results of a 
subsequent study carried out with Caco-2 cells cultured on inserts (Caloni et al., 2005) 
found that FB1 was not absorbed by Caco-2 cells and did not affect the barrier integrity. 
Recently, exposure of Caco-2 cells to 0.001–10 μM FB1 revealed no cytotoxic effect of  
FB1 at all the concentrations tested (Fernandez-Blanco et al., 2016). 
In IPEC-1, a porcine cell line, a significant TEER decrease was reported after 13 days of 
exposure to FB1 (50 µM) (Bouhet et al., 2004). 
The aim of this study was to clarify the in vitro effects of FB1 and BEA, alone and 
combined, on human intestinal Caco-2 cells cultured on inserts through the evaluation 
of TEER and cytokine release. 
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4.2 Materials and methods 
 
4.2.1 Chemicals 
 
Dulbecco’s Modified Eagles Medium (DMEM) high glucose, heat inactivated fetal 
bovine serum (FBS), glutamine, non-essential amino acids (NEAA), N-2-
hydroxyethylpiperazine-N-2'-ethanesulfonic acid (HEPES), penicillin/streptomycin were 
all purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA).  
Fumonisin B1, beauvericin and methanol were all obtained from Sigma-Aldrich 
Chemical Company (St. Louis, MO, USA). 
 
 
4.2.2 Cell culture 
 
Caco-2 cells were purchased from Sigma-Aldrich Chemical Company (St. Louis, 
MO, USA) and routinely grown in an humidified atmosphere of 5% carbon dioxide at 
37°C in DMEM high glucose standard medium supplemented with 100 IU/ml penicillin 
and 100 μg/ml streptomycin, 4 mmol/l glutamine, 1% NEAA, 10 mM HEPES and 
10% heat inactivated FBS. Starting from a cell suspension in culture medium (3 × 105 
cells/ml), the cells were seeded at a density of 1.5 × 105 cells/filter on 4 μm pore size 
12-well plate polyethylene terephthalate (PET) transparent membrane inserts (Millicell®, 
Millipore Corporation) (Fig. 4.1); 0.5 ml of cellular suspension were added in the apical 
(Ap) compartment and 1.5 ml of supplemented DMEM in the basolateral (Bl) 
compartment of each insert. The plate was then shaken gently to avoid non uniform cell 
distribution. 
The plates were transferred to a 37°C, 5% CO2 incubator. Cells were allowed to 
differentiate for 21 days with regular medium changes three times per week. 
The following procedure was used to change the medium on the inserts: first the 
medium from the Bl side of a single well was removed, then the medium from the Ap 
side of the same well was slowly removed avoiding to touch the cellular monolayer with 
the pipet tip; the medium in the Ap compartment was replaced (0.5 ml) first, then in the 
Bl compartment (1.5 ml). This procedure was repeated for each well. The culture was 
regularly checked with an inverted microscope to identify contaminations and/or 
morphological variations. Treatments were applied  at the end of the differentiation 
process. 
 
 
88 
 
 
Figure 4.1: Caco-2 cells cultured on 12 well plate inserts 
 
 
4.2.3 Barrier Integrity Assessment (Trans Epithelial Electrical Resistance Evaluation) 
 
Barrier integrity was assessed by measuring the trans-epithelial electrical resistance 
(TEER) which quantifies the movement of ions across the cell barrier. TEER values 
were recorded in the culture medium at 37°C using an epithelial volthommeter (Millicell-
ERS, Millipore; Fig: 24) just before (0 h) and 1, 2 and 24 h after treatment.     
Before the measurement, the chop-stick electrodes were sterilized. After sterilization, the 
electrodes were placed in the culture medium, both in the Ap and Bl compartments. 
Three separate measurements were quickly performed for each filter and the TEER 
values were calculated with the following equation:  
 
TEER = (Ω cell monolayer – Ω filter cell-free) x filter area 
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Figure 4.2: measurement of TEER 
 
 
4.2.4 Measurement of pro-inflammatory mediator release 
 
After 24 hours of treatment, culture medium was collected from individual wells 
and frozen at -80°C for subsequent pro-inflammatory cytokine release determination.  
In all experiments, the culture medium was analysed for the presence of  interleukin-6 
(IL-6), interleukin-8 (IL-8) and tumour necrosis factor-α (TNF-α) using commercially 
available quantitative ELISA assay kits (Sigma-Aldrich Chemical Company, St. Louis, 
MO, USA).  
 
 
4.2.4.1 IL-6 determination 
 
The ELISA procedure was performed according to the manufacturer’s 
instructions of the Human IL-6 ELISA Kit (Sigma-Aldrich Chemical Company, St. 
Louis, MO, USA). 
Briefly, all reagents and samples were taken to room temperature (18-25°C) before use. 
100 µl of each standard and sample were placed into appropriate wells, covered and 
incubated for 2.5 h at room temperature. All standards were performed in duplicate.  
After incubation, the solution was discarded and the wells were washed 4 times with 1x 
Wash Buffer (300 µl). After the washing step, 100 µl of 1x prepared Biotinylated 
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Detection Antibody were introduced in each well and the plate was incubated for 1 h at 
room temperature. The solution was then discarded and the washing step repeated. 
Successively, 100 µl of prepared HRP-Streptavidin Solution were added to each well and 
incubation was carried out for 45 minutes. The solution was then discarded and after the 
washing step, 100 µl of ELISA Colorimetric TMB Reagent were added to each well. 
After 30 minutes of incubation, 50 µl of Stop Solution were introduced in each well and 
the optical density (OD) was immediately  measured at 450 nm by an ELISA reader 
(Multiskan GO microplate spectrophotometer, Thermo Scientific, Waltham, MA, USA).  
A calibration curve was constructed with eight standard concentrations: 0 pg/ml – 1.37 
pg/ml – 4.12 pg/ml – 12.35 pg/ml – 37.04 pg/ml – 111.1 pg/ml – 333.3 pg/ml – 1000 
pg/ml. After the subtraction of the average zero standard OD, IL-6 sample 
concentration was measured by interpolation from the calibration curve. 
 
 
4.2.4.2 IL-8 determination 
 
The ELISA procedure was performed according to the manufacturer’s 
instructions of the Human IL-8 / CXCL8 ELISA Kit (Sigma-Aldrich Chemical 
Company, St. Louis, MO, USA). 
Briefly, all reagents and samples were taken to room temperature (18-25°C) before use. 
100 µl of each standard and sample were placed into appropriate wells, covered and 
incubated for 2.5 h at room temperature.  
All standards were performed in duplicate and samples were diluted (1:3). 
After incubation, the solution was discarded and the wells were washed 4 times with 1x 
Wash Buffer (300 µl). After the washing step, 100 µl of 1x prepared Biotinylated 
Detection Antibody were introduced in each well and the plate was incubated for 1 h at 
room temperature. The solution was then discarded and the washing step repeated. 
Successively, 100 µl of prepared HRP-Streptavidin Solution were added to each well and 
incubation was carried out for 45 minutes. The solution was then discarded and  after 
the washing step, 100 µl of ELISA Colorimetric TMB Reagent were added to each well. 
After 30 minutes of incubation, 50 µl of Stop Solution were introduced in each well and 
the optical density (OD) was immediately  measured at 450 nm by an ELISA reader 
(Multiskan GO microplate spectrophotometer, Thermo Scientific, Waltham, MA, USA).  
A calibration curve was constructed with eight standard concentrations: 0 pg/ml – 0.8 
pg/ml – 2.5 pg/ml – 7.4 pg/ml – 22.2 pg/ml – 66.7 pg/ml – 200 pg/ml – 600 pg/ml. 
After the subtraction of the average zero standard OD, IL-8 sample concentration was 
measured by interpolation from the calibration curve. 
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4.2.4.3 Tumor Necrosis Factor α determination 
 
The ELISA procedure was performed according to the manufacturer’s 
instructions of the Human Tumor Necrosis Factor α ELISA Kit (Sigma-Aldrich 
Chemical Company, St. Louis, MO, USA). 
Briefly, all reagents and samples were taken to room temperature (18-25°C) before use. 
100 µl of each standard and sample were placed into appropriate wells, covered and 
incubated for 2.5 h at room temperature. All standards were performed in duplicate. 
After incubation, the solution was discarded and the wells were washed 4 times with 1x 
Wash Buffer (300 µl). After the washing step, 100 µl of 1x prepared Biotinylated 
Detection Antibody were introduced in each well and the plate was incubated for 1 h at 
room temperature. The solution was then discarded and the washing step repeated. 
Successively, 100 µl of prepared HRP-Streptavidin Solution were added to each well and 
incubation was carried out for 45 minutes. The solution was then discarded and  after 
the washing step, 100 µl of ELISA Colorimetric TMB Reagent were added to each well. 
After 30 minutes of incubation, 50 µl of Stop Solution were introduced in each well and 
the optical density (OD) was immediately  measured at 450 nm by an ELISA reader 
(Multiskan GO microplate spectrophotometer, Thermo Scientific, Waltham, MA, USA).  
A calibration curve was constructed with eight standard concentrations: 0 pg/ml – 24.58 
pg/ml – 61.44 pg/ml – 153.6 pg/ml – 384 g/ml – 960 pg/ml – 2400 pg/ml – 6000 
pg/ml. After the subtraction of the average zero standard OD, TNF-α sample 
concentration was measured by interpolation from the calibration curve. 
    
 
4.2.5 Experimental Design 
 
Experiment 1 was performed to evaluate the dose response of fumonisin B1 (FB1) 
on Caco-2 barrier integrity and the release of the pro-inflammatory cytokines IL-6, IL-8 
and TNF-α. Caco-2 cells were cultured as previously described and, after differentiation, 
cells were treated with different concentrations of FB1 (0, 0.5, 1.5, 3 µM) in triplicate 
from both Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 h of 
exposure to FB1 by measuring TEER. After 24 h of treatment, medium was collected for 
IL-6, IL-8 and TNF-α determination. 
Experiment 2 was performed to evaluate the dose response of beauvericin (BEA) on 
Caco-2 barrier integrity and the release of the pro-inflammatory cytokines  IL-6, IL-8 
and TNF-α . Caco-2 cells were cultured as previously described and, after differentiation, 
cells were treated with different concentrations of BEA (0, 0.5, 1.5, 3, 6 µM) in triplicate 
from both Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 h of 
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exposure to BEA by measuring TEER. After 24 h of treatment, medium was collected 
for IL-6, IL-8 and TNF-α determination. 
Experiment 3 was designed to evaluate the effects of FB1 (1.5 µM ) and BEA (3 µM), 
alone and combined, on Caco-2 barrier integrity and the release of the pro-inflammatory 
cytokines IL-6, IL-8 and TNF-α. Caco-2 cells were cultured as previously described and, 
after differentiation, cells were treated with FB1 (0 or 1.5 µM) and BEA (0 or 3 µM) in 
triplicate from both Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 
h of exposure to treatments by measuring TEER. After 24 h of treatment, medium was 
collected for IL-6, IL-8 and TNF-α determination. 
 
 
4.2.6 Statistical analysis 
 
Each experiment was performed in triplicate. Results are expressed as mean ± 
standard deviations (SD). Statistical evaluation was performed by two tailed Student’s t-
test. The level of significance was established at P < 0.05. 
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4.3 Results 
 
4.3.1 Experiment 1: effect of fumonisin B1 (FB1) on Caco-2 barrier integrity and cytokine release 
 
 Caco-2 cells were treated with different concentrations of FB1 (0, 0.5, 1.5, 3 µM) 
from both Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 h of 
exposure to FB1 by measuring TEER. After 24 h of treatment, medium was collected for 
IL-6, IL-8 and TNF-α determination. 
No significant (P ≥ 0.05) effect on TEER was observed after 24 h of both Ap and Bl 
exposure to all doses (0.5, 1.5, 3 µM) of FB1 (Fig. 4.3 and 4.4). On one hand, no 
significant release of the inflammatory mediators IL-6 and TNF-α was observed after Ap 
and Bl exposure to FB1 (Fig. 4.5 and 4.7) at all doses (0.5, 1.5, 3 µM). On the other hand, 
a significant (P < 0.05) increase of IL-8 release was induced by Bl exposure to FB1 at 3 
µM (Fig. 4.6 ). 
 
 
 
Figure 4.3: Effect of FB1 on Caco-2 TEER values after apical exposure. Graph shows the mean values and 
standard deviations (n=3). (*) P < 0.05. 
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Figure 4.4: Effect of FB1 on Caco-2 TEER values after basolateral exposure. Graph shows the mean values and 
standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
Figure 4.5: Effect of FB1 on Caco-2 IL-6 release after apical and basolateral exposure. Graph shows the mean 
values and standard deviations (n=3). (*) P < 0.05. 
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Figure 4.6: Effect of FB1 on Caco-2 IL-8 release after apical and basolateral exposure. Graph shows the mean 
values and standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
Figure 4.7: Effect of FB1 on Caco-2 TNF-α release after apical and basolateral exposure. Graph shows the 
mean values and standard deviations (n=3). (*) P < 0.05. 
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4.3.2 Experiment 2: effect of beauvericin (BEA) on Caco-2 barrier integrity and cytokine release 
 
 Caco-2 cells were treated with different concentrations of BEA (0, 0.5, 1.5, 3, 6 
µM) from both Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 h of 
exposure to BEA by measuring TEER. After 24 h of treatment, medium was collected 
for IL-6, IL-8 and TNF-α determination. 
TEER was not significantly affected (P ≥ 0.05) by Ap exposure to all doses of BEA (Fig. 
4.8). On the contrary, a significant (P < 0.05) TEER decrease was observed after Bl 
exposure to BEA at 0.5 and 1.5 µM starting from the first hour of treatment (Fig. 4.9). 
This decrease in TEER was no more observed after 24 h of Bl exposure to BEA at 1.5 
µM. Differently, at higher concentrations (3 and 6 µM), BEA was found to significantly 
(P < 0.05) increase TEER after 24 h of Bl exposure (Fig. 4.9). 
A significant release of the inflammatory mediator IL-6 was observed after Ap exposure 
to BEA at 3 and 6 µM and after Bl exposure to BEA at 1.5, 3 and 6 µM (Fig. 4.10). 
Regarding IL-8, a significant (P < 0.05) release was induced by Ap exposure to BEA at 3 
and 6 µM and by Bl exposure to BEA only at 6 µM (Fig. 4.11). 
Concerning TNF-α, a significant release was observed after Ap exposure to 0.5 and 1.5 
μM BEA and after Bl exposure to 1.5 μM BEA (Fig. 4.12). 
 
 
Figure 4.8: Effect of BEA on Caco-2 TEER values after apical exposure. Graph shows the mean values and 
standard deviations (n=3). (*) P < 0.05. 
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Figure 4.9: Effect of BEA on Caco-2 TEER values after basolateral exposure. Graph shows the mean values 
and standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
 
Figure 4.10: Effect of BEA on Caco-2 IL-6 release after apical and basolateral exposure. Graph shows the mean 
values and standard deviations (n=3). (*) P < 0.05. 
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Figure 4.11: Effect of BEA on Caco-2 IL-8 release after apical and basolateral exposure. Graph shows the mean 
values and standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
 
Figure 4.12: Effect of BEA on Caco-2 TNF-α release after apical and basolateral exposure. Graph shows the 
mean values and standard deviations (n=3). (*) P < 0.05. 
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4.3.3 Experiment 3: individual and combined effects of fumonisin B1 and beauvericin (BEA) on Caco-
2 barrier integrity and cytokine release 
 
 Caco-2 cells were treated with FB1 (0 or 1.5 µM) and BEA (0 or 3 µM) from both 
Ap and Bl sides. The barrier integrity was evaluated after 1, 2 and 24 h of exposure to 
treatments by measuring TEER. After 24 h of treatment, medium was collected for IL-6, 
IL-8 and TNF-α determination. 
No significant (P ≥ 0.05) effect was observed on TEER after 24 h of Ap exposure to 
FB1 at 1.5 µM, BEA at 3 µM and the combination of these mycotoxins (Fig. 4.13). Only 
after 24 h of Bl exposure to BEA at 3 µM a significant (P < 0.05) increase of TEER was 
observed (Fig. 4.14). This TEER increase was not observed after Bl exposure to BEA at 
3 µM in combination with FB1 at 1.5 µM (Fig. 4.14)  
FB1 and BEA, alone and combined, had no significant effects on cytokine release (Fig. 
4.15, 4.16, 4.17).  
 
 
 
Figure 4.13: Effect of FB1 with or without BEA on Caco-2 TEER values after apical exposure. Graph shows 
the mean values and standard deviations (n=3). (*) P < 0.05. 
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Figure 4.14: Effect of FB1 with or without BEA on Caco-2 TEER values after basolateral exposure. Graph 
shows the mean values and standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
Figure 4.15: Effect of FB1 with or without BEA on Caco-2 IL-6 release after apical and basolateral exposure. 
Graph shows the mean values and standard deviations (n=3). (*) P < 0.05. 
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Figure 4.16: Effect of FB1 with or without BEA on Caco-2 IL-8 release after apical and basolateral exposure. 
Graph shows the mean values and standard deviations (n=3). (*) P < 0.05. 
 
 
 
 
 
Figure 4.17: Effect of FB1 with or without BEA on Caco-2 TNF-α release after apical and basolateral exposure. 
Graph shows the mean values and standard deviations (n=3). (*) P < 0.05. 
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4.4 Discussion 
 
The gastrointestinal tract is an important environment responsible for absorbing 
nutrients, protecting the body against pathogens entering with food and preventing the 
loss of important compounds such as water and solutes (Gordon et al., 2015). The 
integrity of the intestinal barrier is crucial for the maintenance of the homeostasis (Goto 
and Kiyono, 2012). An impairment of the intestinal barrier function may cause 
autoimmune responses, inflammation and atopic diseases (Antonissen et al., 2014). 
The trans-epithelial electrical resistance (TEER) is a parameter that gives information on 
the barrier integrity and its decrease corresponds to an impairment (Marin et al., 2015). 
TEER is considered a good indicator of the organization of the TJ proteins (Pinton et 
al., 2009). TJ proteins seal the intercellular space between adherent epithelial cells, thus 
preventing paracelluar transport of luminal antigens (Schneeberger and Lynch, 1992; Liu 
et al., 2000; Tsukita et al., 2001; Maresca and Fantini, 2010). TJ proteins are therefore 
involved in barrier function and their damage leads to an increase of the intestinal 
permeability and thus to an increased transepithelial passage of bacteria and antigens 
(Maresca and Fantini, 2010). The number of TJ strands and their ramification depend on 
the cell type, producing marked variation in the morphology of TJ strand networks. The 
main TJ integral membrane proteins are occludins (OCLN), claudins (CLDN) and 
junctional adhesion molecules (JAM) (Tsukita et al., 2001; Maresca and Fantini, 2010).  
The ability of FB1 to cause toxicity on intestinal epithelial cell lines have been already 
reported. Bouhet et al. (2004) showed that FB1 at concentrations ranging from 2 to 700 
µM decreased in a time- and dose-dependent manner TEER of IPEC-1 cells (Bouhet et 
al., 2004). The authors reported a significant TEER decrease after 13-day exposure to 
FB1 at 50 µM and a drastic impairment of the intestinal barrier integrity after 15 to 18 
days of exposure to high concentrations of FB1 (200 and 500 µM) (Bouhet et al., 2004).  
FB1 (1 to 138 μM) was previously reported to not exert cytotoxic effects on Caco-2 cells 
(Caloni et al., 2002). Only a transient decrease of TEER was observed after 6-h exposure 
to the highest concentration tested, without FB1 epithelial passage (Caloni et al., 2005; 
De Angelis et al., 2005). Recently, after treatments with FB1 at 1, 3, 10, 30 μM a 
reduction in mRNA levels of CLDN3 and CLDN4  transmembrane proteins  was 
observed in FB1-exposed Caco-2 cells showing the ability of FB1 to impair the intestinal 
barrier integrity (Romero et al., 2016). 
In our study no significant effect (P ≥ 0.05) was observed on TEER after 1, 2 or 24 h of  
Apical (Ap) or Basolateral (Bl) exposure to all the doses of FB1 (0.5, 1.5, 3 µM) (Fig. 4.3; 
4.4). Our results are in agreement with previous studies (Wentzel et al., 2016) where 
Caco-2 cells were exposed for 24 h to different concentrations (0.5–45 µM) of FB1. The 
results reported by Wentzel et al. (2016) showed that even at concentrations up to 45 
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µM, FB1 did not affect cells. Similarly, exposure of Caco-2 cells to 0.001–10 μM FB1 
revealed no cytotoxic effect of  FB1 at all the concentrations tested (Fernandez-Blanco et 
al., 2016). 
Based on our findings FB1 induced IL-8 release in Caco-2 cells even if only after Bl 
exposure to FB1 at 3 µM (Fig. 4.6), while no significant release of IL-6 or TNF-α was 
observed after Ap and Bl exposure to FB1 at all doses (0.5, 1.5, 3 µM) (Fig. 4.5). 
The significant (P < 0.05) increase of IL-8 release induced by Bl exposure to FB1 (3 µM) 
(Fig. 4.6) was previously observed but after exposure to a higher concentration of FB1 
(17.2 μM) (Minervini et al., 2014). 
Regarding BEA its cytotoxicity was observed on Caco-2 cells at 20.6 and 12.7 μM after 
24 and 48 h exposure, respectively (Prosperini et al. 2012) and at 1 and 10 μM 
(Fernandez-Blanco et al., 2016).  
In our study a significant (P < 0.05) TEER decrease was observed after 1 h and 2 h of Bl 
exposure to BEA at 0.5 and 1.5 µM and after 24 h of Bl exposure to BEA at 0.5 µM,  
whereas after 24 h of Bl exposure, BEA at 3 and 6 µM was found to significantly (P < 
0.05) increase TEER (Fig. 4.9). When forced by an inducible promoter, an over-
expression of OCLN leaded to a TEER increase of MDCK cells in a reversible manner, 
paradoxically increasing the paracellular flow of uncharged solutions (McCarthy et al., 
1996). This paradoxical behavior still needs to be clarified (Barrett and Donowitz et al., 
2001).  Phosphorylation of TJ proteins, in particular CLDN, has also been shown to 
affect the epithelial barrier function (Stevenson et al. 1989; Findley et al., 2009). 
Moreover, protein kinase C (PKC) is involved in TJ regulation and has been 
demonstrated to act through an increase or decrease of TEER (Farhadi et al. 2006; 
Plotnikov et al., 2010). 
The increase of TEER induced by BEA may be related to the modulation of TJ 
proteins, like claudin-2 and OCLN, with the effect of improving overall epithelial barrier 
function.  
A significant (P < 0.05) release of IL-8 was induced by Ap exposure to BEA at 3 and 6 
µM and by Bl exposure to BEA only at 6 µM (Fig. 4.11).  
Concerning TNF-α, a significant release was observed after Ap exposure to 0.5 and 1.5 
µM BEA and after Bl exposure to 1.5 µM BEA (Fig. 4.12).  
In the present study the combined effects of FB1 and BEA on Caco-2 cells were also 
evaluated.   
After 24 h of Bl exposure, BEA alone at 3 µM increased TEER (P < 0.05), but this 
effect was no longer observed when combined with FB1 (Fig. 4.14), which shows no 
effect at 1.5 µM after 1, 2 and 24 h of Ap or Bl exposure (P ≥ 0.05) (Fig. 4.13). These 
results suggest a possible interaction between these mycotoxins.  
As previously discussed BEA alone was found to increase IL-6 and IL-8 release (Fig. 
4.10; 4.11), but these increased releases were not observed when BEA was combined 
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with FB1 (Fig. 4.15; 4.16), which induces  IL-8 release at 3 µM. Ap (0.5 -1.5 µM) and Bl 
(1.5 µM) exposure to BEA increased TNF-α release (Fig. 4.12), but not in the presence 
of FB1 (Fig. 4.17). 
TNF-α seems to play a key role in intestinal inflammation exerting a protective effect on 
the intestinal barrier function (Corridoni et al., 2012; Naito et al., 2003; Noti et al., 2010). 
The mechanisms of FB1 toxicity include inhibition of ceramide synthase and 
accumulation of sphingoid bases, repression of protein kinase C and its down-stream 
effector TNF-α and mobilization of cellular calcium (Kim et al., 2006; Gopee et al., 
2003). On the other hand BEA increases intracellular calcium and activates the calcium-
dependent endonucleases and causes subsequent DNA fragmentation (Jestoi, 2008). 
Only few studies so far have investigated the in vitro interactions between FB1 and BEA, 
however synergic effects of these mycotoxins have been already reported (Klaric et al., 
2007), even if the exact mechanism of the interaction needs to be clarified. 
In this study FB1 did not exert significant adverse effects on intestinal Caco-2 cells 
cultured on inserts, while BEA alone affected TEER and induced cytokine release but, 
in combination with FB1, these effects were no more observed. The disappearance of 
IL-6 and IL-8 release induced by BEA, may suggest a possible protective action of FB1 
(Cuzzocrea et al., 2008).  
Our results suggest an interaction between FB1 and BEA when combined on TEER and 
cytokine release of in vitro intestinal Caco-2 cells. Other studies are in progress to better 
understand these aspects. 
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